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PERSISTENCE AND REACTIVATION
Molecular and Cellular Analysis of Chlamydia trachomatis 
Persistence and Reactivation
by
Kimberly R. Tau
Chlamvdia trachomatis (CT) is the most prevalent sexually-transmitted 
infection in the United States. It has been suggested that CT infections can become 
latent. This has not been substantiated. CT persistence was examined at the 
molecular and cellular level in vitro and in vivo.
Penicillin treatment of CT in vitro results in abnormal inclusions and reduced 
recovery of infectious CT. Penicillin did not inhibit initial stages of infection, but did 
downregulate CT rRNA levels after 25 hours post-inoculation (p.i.). DNA 
amplification was employed to differentiate between a resolved infection and a 
persistent one. Utilizing a primer pair that amplified a 144 bp fragment in the CT 
MOMP gene, CT-persistently-infected McCoy cells maintained in penicillin medium 
were examined. Though undetectable by other assay methods, these cells harbored 
the CT genome for 18 passages. Removal of penicillin 1, 3 or 6 passages p.i. and 
subsequent cultivation in permissive medium resulted in "recovery" to productive 
infection. Removal of penicillin at later passages resulted in low level inclusion 
formation but no infectious progeny. Penicillin treatment in vitro resulted in a 
persistent infection undetectable by most methods.
Female C3H/HeNCRL mice were inoculated with CT intrauterinely and 
intravaginally in two separate experiments. In one, CT infection was established in 
untreated and Depo-Provera (DP)-pretreated mice. DP pretreatment enhanced vaginal 
shedding of infectious CT. A negative vaginal culture did not correlate with 
elimination of CT from the upper tract. In the second, penicillin therapy did not halt 
vaginal CT shedding, however, it reduced frequency of recurrent vaginal CT 
shedding. To examine reactivation, culture-negative mice (> 2  successive vaginal 
cultures) were injected with cortisone-acetate (CA) or DP; mice from same 
subpopulation injected with saline served as controls. Transient vaginal CT shedding 
was reactivated in penicillin-treated mice (14% CA-injected), and in unmedicated 
mice (28% CA-injected, 33% DP-injected). Saline injection did not reactivate vaginal 
CT shedding. At time of sacrifice (16 or 22 weeks p.i.) no infectious CT was 
detected in upper tract tissues, although tissue damage was observed in most mice 
(70-71%). It is unknown if these mice harbored a persistent infection undetectable by 
culture. Further work utilizing molecular techniques is needed to resolve this 
question.
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CHAFFER 1 
Introduction
General Characteristics of the Genus Chlamvdia 
The Chlamvdiae belong to a unique genus of obligate intracellular prokaryotes 
that invade eukaryotic cells, parasitizing high energy compounds and other nutrients. 
The members of the genus share certain traits including an obligate intracellular 
habitat, a developmental cycle with two morphologically distinct forms, an inability to 
synthesize high energy compounds, and a very small genome (660 MDa) (Moulder 
1988). The genus currently contains three recognized species: Chlamvdia psittaci. 
Chlamydia trachomatis f e n  and Chlamvdia pneumoniae. £ . psittaci is a recognized 
cause of diverse veterinary and human disease states including abortion in sheep and 
cattle, pneumonia, airsacculitis, arthritis, polyarthritis-polyserositis, urogenital 
infections, mastitis, intestinal infections, enteritis in ruminants and chlamydiosis in 
wild and domesticated birds (Storz 1988). £ . psittaci is less host- and tissue-specific, 
with less homogeneity within the species than is CT. CT is composed of three 
biovars (distinctive variations between members of the same species determined by 
biological differences): lymphogranuloma venereum (LGV), trachoma inclusion 
conjunctivitis agents (TRIC), and mouse pneumonitis (MoPn), LGV is a highly 
invasive pathogen with a tropism for lymphoid tissue. LGV is the etiologic agent of 
lymphogranuloma venereum, a sexually-transmitted disease that is fairly rare in the 
United States, but is far more common in other parts of the world including Southeast
1
Asia, India, and Africa (Schachter 1988). The TRIC agents cause a variety of disease 
including trachoma, the leading cause of preventable blindness in the world. There 
are eighteen serovars of CT, four of which are associated with endemic trachoma (A, 
B, Ba and C), four with LGV (LI, L2, L2a and L3); the other serovars are primarily 
associated with genital and neonatal infections (Freeman 1985, Wang and Grayston 
1991). There is nearly 10096 DNA homology shared by the LGV and TRIC biovars, 
even though each causes distinctly different diseases (Moulder 1988). In contrast, 
MoPn, the only nonhuman biovar of CT, shares only 30-60% DNA homology with 
the other biovars of CT (Moulder 1988). MoPn, the murine biovar of CT generally 
causes a pneumonia, but has been used to establish genital infections experimentally. 
£ .  pneumoniae has been determined to be an important human pathogen, causing 
pneumonia in adults as well as neonates. It is biochemically distinct from £ .  psittaci. 
the species in which it was once classified (Patton, personal communication).
Developmental Cycle of CT 
Although once thought to be a virus due to its obligate intracellular nature, 
subsequent analysis demonstrated that CT is a prokaryote as it contains both DNA and 
RNA. CT contains three species of rRNA: 21s, 16s, and 4s (Newhall 1988). This 
unusual bacterium has a very small genome (660 MDa) that does not code for the 
respiratory enzymes necessary to synthesize high energy compounds. Although 
glutamate, glucose, and pyruvate can be catabolized to a certain extent, this is not 
sufficient for survival, thus CT is entirely dependent upon the host cell for energy
(Moulder 1988). CT is classified as a gram-negative bacterium as a component of its 
cell wall is a lipopolysaccharide (LPS) chemically similar to enterobacterial Re LPS 
(Hearn and McNabb 1991). CT is unique as no peptidoglycan layer has been 
demonstrated nor has muramic acid been detected as a component of its cell wall, 
although CT does possess three penicillin binding proteins (Barbour et al. 1982, How 
et al. 1984). The latter distinguishes it from other bacteria which do not contain 
peptidoglycan, such as most Mycoplasmas.
CT has a unique biphasic developmental cycle that alternates between two 
morphologically distinct forms: an infectious, metabolically inert elementary body 
(EB) and a noninfectious, metabolically active reticulate body (RB). The EB is 
adapted to the extracellular environment, while the fragile RB is adapted to the 
intracellular environment. Each has a distinct morphology and chemical composition. 
The EB (400-600nm diameter) has a dense nucleus at an eccentric region and a 
cytoplasm that is composed of ribosomes and an amorphous material (Matsumoto 
1988). The cell wall of the EB is highly disulfide cross-linked and contains at least 
one protein that is not found in the RB: the 60 KDa cysteine-rich outer membrane 
protein (Hatch 1988, Moulder 1991). The RB (size, 800-1200 nm, diameter) is 
surrounded by two trilaminar membranes (cell wall and cytoplasmic membranes) and 
tends to have a homogeneous distribution of ribosomes in the cytoplasm.
CT development consists of a multistep cycle that can be influenced at a 
number of steps to produce differing end results (Figure 1). Host cell ingestion of the 
extracellular EB is essential to CT development with attachment and entry being two
Figure 1 
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distinct processes (Byrne 1978). Evidence suggests that uptake is via a receptor- 
mediated endocytosis, possibly using host cell receptors (Hodinka et al. 1988, Wyrick 
et al. 1989). CT may use more than one mode of entry, dependent upon the mode of 
presentation to the cell, the strain of CT and the type of host cell Another important 
step in the chlamydial life cycle is inhibition of endolysosomal fusion to prevent 
degradation of the EB. It has been postulated that some strains of CT fail to grow in 
certain host cells due to their inability to stabilize the endolysosomal membrane and 
prevent degradation of the EB (Prain and Pearce 1985).
Within a few hours after attachment and entry, the EB begins to mature into 
the RB that is the replicative form capable of binary fission. RB metabolism relies 
upon the host cell for high energy compounds, vitamins, amino acids, nucleotides, 
and other essential nutrients. CT competes with the host cell for these nutrients such 
that if levels drop below a critical threshold, CT development ceases until the 
deprivation is reversed. As the RBs divide, the inclusion becomes filled with 
glycogen (18 hours post-inoculation). This glycogen is within the phagosome but is 
extrachlamydial. This glycogen synthesis appears to be due to a chlamydial enzyme 
rather than a cellular enzyme, but the purpose is unknown (Moulder 1988). The 
presence of glycogen in the inclusion is a major morphologic difference between CT 
and £ . psittaci or £ .  pneumoniae as the latter do not sequester glycogen in the 
inclusion. At some point in the cycle, an unknown signal results in RB maturation 
into EBs. Although the assumption is that a single RB gives rise to a single EB, this 
has not been proven. Ultrastructural analysis has demonstrated that condensation of
the DNA may occur at several sites in the RB cytoplasm which suggests that a single 
RB can mature into more than one EB (Ward 1988). The regulation of the CT 
developmental cycle is poorly understood. Recent work has demonstrated that 
expression of sets of temporally distinct proteins throughout the CT developmental 
cycle may be regulated by a series of promoters recognized in sequence, either by 
cycle-dependent sigma factors or other regulatory DNA-binding proteins (Hatch et al. 
1990, Moulder 1991). The maturation of RB to EB may be more complex than 
originally thought, possibly dependent upon signals generated in response to 
environmental stimuli. Cyclic nucleotides have a distinct role in CT regulation. Low 
levels of cyclic GMP act as a stimulator and high levels of cyclic AMP as an inhibitor 
of CT development (Ward and Salari 1982). The inhibitory effect of cyclic AMP is 
due to regulation at the transcriptional level (Kaul et al. 1990). Complex regulatory 
pathways appear to exist that can influence CT at many stages during development.
EB maturation from the RB includes expression and incorporation of at least one EB- 
specific protein (60 KDa cysteine-rich outer membrane protein), extensive cross- 
linking of proteins in the cell wall as well as other modifications that have not yet 
been clearly elucidated.
Several mechanisms of CT release have been proposed. In tissue culture the 
predominant mechanism of release appears to be lytic disruption of the cell and 
subsequent dispersal of EBs (Ward 198B). In vivo, a lytic mode of release would 
result in tissue damage, which would explain some of the pathogenesis o f the invasive 
chlamydiae such as LGV, but does not account for the greater majority of chronic,
asymptomatic CT infections observed. Exocytosis without concommitant cell death 
has been demonstrated in vitro, with EBs budding from HeLa cells (Todd and 
Caldwell 1985). Cell-to-cell transfer of CT also occurs either by infection of adjacent 
cells or transfer of the inclusion to daughter cells during cell division (Lee and 
Moulder 1981, Moulder 1991). CT may not be limited to a single mode of release, 
rather conditions in the host cell may dictate what mechanism is used. The 
mechanism used would influence the type of damage done to the infected tissue.
ClinicaLEeatures.and_Epidemio1ogv of Genital CT Infections 
CT is the most prevalent sexually-transmitted infection in the United States, 
with over four million new cases diagnosed annually (CDC 1985, Holmes 1981, 
Schachter 1978). CT infects men, women, and infants, but the consequences of such 
infection can be particularly serious in women. Genital infection by CT in women 
can result in a broad range of disease from a negligibly mild cervicitis to more 
serious sequelae including mucopurulent cervicitis, urethral syndrome, acute pelvic 
inflammatory disease (FID), salpingitis, involuntary infertility, peritonitis, and 
perihepatitis (CDC 1985, Lipkin et al. 1986). CT is now recognized as the leading 
cause of PID, resulting in 25% to 50% of the estimated 1,000,000 cases a year in the 
United States (Maslow et al. 1988). CT has also been implicated as the etiologic 
agent in a significant number of cases of ectopic pregnancy and tubal infertility 
(Henry-Suchet 2988, Walters et al. 1988, Quinn et al. 1987, Chow et al. 1990). 
Whether or not CT infection can have a deleterious effect upon pregnancy is still
debated. It has been reported that CT-infected pregnant women have a significantly 
higher rate of premature births and increased perinatal mortality (Martin et al. 1982), 
while another study had contrasting results (Alexander and Harrison 1983). CT 
infection has been implicated as a  causative agent of spontaneous abortion, but this 
has not been substantiated (Quinn et al. 1987). There has been one report of fetal 
death from CT pneumonia that occurred across intact amniotic membranes, suggesting 
that CT can infect the fetus in utero. but this has not yet been definitively established 
(Thorp et al. 1989). The effect of CT upon pregnancy needs to be determined as the 
estimated prevalence of CT infection in pregnant women is 2% to 25% and is 
increasing. Infants delivered from an infected mother have a high incidence of 
inclusion conjunctivitis, pneumonia, otitis media, and gastroenteritis (Schaefer et al. 
1985).
More severe complications may be the result of long-term CT infections that 
have gone untreated. In one study, of over 5000 women in upper East Tennessee, 
nearly two-thirds of those culture-positive for CT were clinically asymptomatic 
(Campbell and Dodson 1990). It has not been determined if all untreated 
asymptomatic infections will eventually progress to more serious sequelae. One of 
the unresolved questions in CT research is why there is such a broad range of disease 
states, with one women showing no apparent symptoms, while another women rapidly 
develops acute PID. Further work is required to determine mechanisms of CT 
pathogenesis and to define the factors which place a patient at greater risk for 
development of the more serious sequelae of CT infection. Conversely, the factors
9which place a woman at risk of establishing an undetectably persistent CT infection 
are also unknown. Establishment of a persistent CT infection could result in 
reactivation at a later time, which eventually may lead to irreparable tissue damage.
Persistent CT Infections 
There are many unresolved questions concerning pathogenesis of CT. There is 
circumstantial evidence that persistent or latent CT infections may occur, but this 
evidence is controversial. It has been suggested that CT infections can become latent, 
with reactivation at a later time by superinfection or steroid treatment (Oriel and 
Ridgway 1982, Yang et al. 1983). There have been documented cases of women that 
had been CT culture-positive subsequently becoming CT culture-negative in the 
absence of therapy (McCormack et al. 1979, Rahm et al. 1988). In one 
epidemiologic study, 25 women that had been CT culture-positive were reexamined 
one to two years later (McCormack et al. 1979). During this reexamination, three 
women who had been CT culture-negative, but CT antigen-positive, became CT 
culture-positive (McCormack et al. 1979). This implies that these women developed 
an infection undetectable by culture that later "reactivated", however reinfection has 
not been excluded. In a later study, a postponement in culture created a 10 week 
delay in treatment for 109 CT culture-positive women (Rahm et al. 1988). During 
those ten weeks, 17.5% of the patients developed symptoms of a genital infection and 
one was hospitalized for PID. It was also noted that 17 had become CT culture- 
negative without any treatment (Rahm et al. 1988). It has not been determined if
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these women cleared the CT infection or if they developed undetectable persistent 
infections. In several retrospective studies, tissues from males with cystitis or 
prostatitis were stained with a monoclonal antibody against Chlamidia genus-specific 
antigen (Shurbaji et al. 19S8, Shuibaji et al. 1990). The striking observation in these 
studies was that in a population with an average age of 60-61 years, chlamydial 
antigens were detected in 31-33% of the patients. This is an unusual result as 
prevalence of CT cervicitis is inversely related to age (Thompson and Washington 
1983, Campbell and Dodson 1990).
It has not been established whether these observations reflect true latent or 
undetectable persistent CT infections. As culture is the "gold standard” for CT 
detection, a positive result using any other assay method is defined as a false positive. 
However, if CT can establish a persistent infection that is not detectable by culture 
than other assay methods may be more accurate and reflect the true state of infection 
in the patient. It has been noted with several nonculture techniques that some patients 
remain positive by several antigen-based assays, yet are CT-culture-negative 
(Schachter et al. 1988). This may support further the hypothesis that CT can 
establish persistent infections that can not be detected by culture. However, the 
question still remains unresolved.
One difficulty with the study of "persistent” CT infections is the definition of 
"latency" and "persistence". True latency, from a virology viewpoint, is a state in 
which the infectious agent remains in the host, but there are few signs of illness and 
no replication, i.e. no infectious progeny produced. The nucleic acid of the latent
IX
agent may or may not be integrated into the host genome. A persistent infection can 
be defined as a  chronic infection that has a low level of replication, with or without 
the production of infectious progeny. Even though it has been hypothesized that CT 
can establish "latent" infections, it is still undetermined whether or not these are true 
latent infections. It is possible that "latent" CT infections are actually persistent 
infections or active CT infections that are sequestered in the upper reproductive tract, 
undetectable by vaginal or cervical specimen collection.
Persistent CT infections have been demonstrated in vitro. Lee and Moulder 
(1981) persistently-infected McCoy cells with CT and noted that these cells underwent 
cycles of "wipeout", i.e. cycles of cell lysis followed by cellular regeneration.
Another model of in vitro CT infection overlaid fresh cells onto CT-infected cells to 
demonstrate cell-to-cell transfer of CT (Benes 1990). Although, in L cells 
persistently infected by £ . psittaci, a "cryptic form" has been described which 
remains hidden until some factor causes its conversion to RB, an analogous structure 
has not yet been found in CT persistently-infected cells (Moulder et al. 1980). The 
underlying mechanism(s) of CT persistence have not yet been determined, nor has the 
correlation of in vitro persistence to human CT infections been established.
The key to CT persistence may reside in modulators of infection. Steroid 
hormones (estrogen and progesterone), antibiotics (penicillin and chloramphenicol), 
and lymphokines (interferon-? and tumor necrosis factor (TNF)) have been 
demonstrated to influence the outcome of CT infection (Byrne et al. 1989, Sarov et 
al. 1991). These compounds may affect the severity of the infection, the mode of
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pathogenesis or the outcome, i.e. subclinical persistence vs. immune clearance. For 
example, women who take oral contraceptives seem to be more susceptible to CT 
infection (Louv et al. 1989, Kinghom and Waugh 1981, Washington et al. 1985). 
Some evidence indicates that progesterone and estrogen may directly enhance the 
susceptibility of the cells to CT infection (Tau-Cody et al. 1988, Maslow et al. 1988). 
Progesterone and estrogen have been shown to affect CT infections in vivo and in 
vitro (Rank et al. 1982, Tuffrey et al. 1986a, Bose and Goswami 1986). Another 
effect of steroid hormones may be reactivation of persistent infection. In one report, 
coitisone-acetate treatment "reactivated" a  latent CT lung infection in mice (Yang et 
al. 1983). The developmental cycle of CT has complex regulatory mechanisms that 
seem to be exquisitely sensitive to environmental stimuli.
Penicillin Mechanisms of Action 
The classic mechanism of action of penicillin is the disruption of peptidoglycan 
synthesis by competitive inhibition of the transpeptidases responsible for cross-linking 
the pentapeptide to adjacent glycine bridges, which result in a network of cross* 
linkages that give the bacterial cell wall three dimensional structure and rigidity. The 
peptidoglycan synthetic pathway and its inhibitors are summarized in Figure 2. It is 
interesting to note that the transpeptidases have acquired the label "penicillin binding 
proteins" as they can be isolated and their concentration determined by the uptake of 
radioactive penicillin.
As CT does not contain detectable peptidoglycan, it is an enigma as to how
Figure 2
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penicillin affects CT synthesis. Other bacteria without peptidoglycan and Lrforms are 
not susceptible to penicillin (Moulder 1991). CT does contain three penicillin binding 
proteins (88, 61 and 36 KDa), but these have not been characterized (Barbour et al. 
1982). Other antibiotics that inhibit various steps of classic cell wall synthesis have 
varying effects upon CT replication. Penicillin (and other /Mactams), cycloserine and 
bacitracin have antichlamydial activity, while alaphosphin, phosphomycin, and 
vancomycin exhibit no antichlamydial activity (Moulder et al. 1963, How et al.
1984). It has also been demonstrated that preincubation of CT EBs with enzymes 
known to cleave peptidoglycan had no adverse effect upon subsequent CT replication, 
further supporting the absence of a peptidoglycan layer (How et al. 1984). Early 
ultrastructure studies of the effect of penicillin upon £ . psittaci and CT replication 
indicated that inhibition of EB maturation had occurred, resulting in abnormally large 
"RBs" (Matsumoto and Manire 1970, Kramer and Gordon 1971). Theseultrastructure 
studies also suggested that penicillin treatment of Chlamvdia inhibits RB binary 
fission, although an earlier report based upon biochemical and culture data contradicts 
this (Tamura and Manire 1968). The observation that penicillin treatment of CT- 
infected McCoy cells results in abnormal inclusion formation further supports the 
hypothesis that penicillin inhibits maturation of the RB into the EB, but does not 
inhibit the initial stages of the developmental cycle (Johnson and Hobson 1977). 
Several mechanisms have been hypothesized to explain the unusual effect of penicillin 
upon CT replication. One hypothesis suggests that the classic mechanism of penicillin 
action is employed, however the component of the cell wall that resembles a
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peptidoglycan side chain is linked to a structure other than muramic acid (Moulder 
1991). A second hypothesis has suggested that abnormal forms are derived from EBs 
in a process analogous to spheroplast formation in other peptidoglycan-containing 
bacteria (Johnson and Hobson 1977). A third hypothesis has suggested that the 
penicillin-binding proteins found in CT have assumed new functions completely 
unrelated to peptidoglycan synthesis but essential to KB to EB maturation, i.e. 
possibly catalyzing the extensive cross-linking found in EB cell walls (Johnson and 
Hobson 1977). The outcome of penicillin treatment upon CT-infected cells could be 
very different depending upon the exact mechanism employed, i.e. eradication of the 
infection vs. establishment of a persistent infection. These questions have not been 
resolved.
Murine Model of CT Genital Infection 
Development of animal model systems to study CT has been difficult since 
man is the only natural host, with the exception of the MoFn biovar. Although model 
systems of genital infection have been developed using rabbits, guinea pigs, and 
nonhuman primates, the mouse model seems to be the most efficient and economical 
model for these studies. Mice have been experimentally inoculated with human 
strains of CT and MoPn (Barron et al. 1984, Tuffrey et al. 1986a). Inoculation of 
CT into the upper genital tract of susceptible mice has been demonstrated to cause in 
salpingitis, as well as infertility (Tuffrey et al. 1986b, Tuffrey et al. 1990, Zana et al. 
1990). The murine model of genital CT infection has been increasingly used over the
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past few years, resulting in a growing body of literature concerning pathogenesis, the 
immune response to CT, and the effects of various antimicrobial agents upon CT 
replication and pathogenesis.
Although relatively poorly understood, the immune response to CT genital 
infection has been studied by a number of groups. Humoral immunity does not 
appear to play a role in protective immunity or in immune clearance of CT since 
reinfection can occur whether the animals were immunized or infected prior to 
challenge (Tuffrey et al. 1984, Ito and Lyons 1991). It has also been demonstrated 
that B-cell deficient mice appear to resolve genital MoPn infection as well as normal 
mice, further supporting the hypothesis that the humoral response is not effective 
against CT infection (Ramsey et al. 1988). T cells appear to be more important in 
CT immune clearance and have been implicated as the source of the limited immunity 
observed in CT infections. Nude mice infected with MoPn have been demonstrated 
to develop a persistent infection and this infection can be resolved by adoptive 
transfer of certain CT-specific T cell clones (Igietsume et al. 1991).
The immune response to CT infection appears to be protective and 
destructive. Although previous exposure appears to result in limited protection, 
challenge can result in more severe pathogenesis (Tuffrey et al. 1990). At least one 
CT protein (57 KDa) has been implicated in delayed hypersensitivity reactions in an 
ocular model of CT infection (Morrison et al. 1989). In a  separate model system 
examining sexually-acquired reactive arthritis, mice that are sensitized to CT either by 
immunization or inoculation develop reactive arthritis upon intra-articular challenge
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(Hough and Rank 1988, Hough and Rank 1989). The mechanisms of CT 
pathogenesis are still not well understood but a growing body of evidence suggests 
that the immune response may play an important role in tissue damage.
CT infections in mice are considered to be "self-limiting" with resolution of 
the infection generally determined by the absence of infectious CT in vaginal 
secretions (Tuffrey et al. 1984). Although persistent or latent CT infections have 
been hypothesized in humans, this has not been closely examined in the murine model 
of genital CT infection. Further work is needed to determine if persistent or latent 
CT infections occur in the murine model and, if so, the nature of this host-pathogen 
interaction.
Rationale and Goals 
As the ability of CT to establish persistent infections could have a profound 
effect not only upon diagnosis, but also treatment, a greater understanding of the 
mechanisms of CT persistence and reactivation could have a significant impact upon 
clinical management of this infection. It was the goal of this project to develop in 
vitro and in vivo models necessary to examine CT persistence and reactivation at the 
cellular and molecular level. CT persistence in vitro was examined by using the 
effect of penicillin upon CT infection in McCoy cells. CT persistence and 
reactivation in vivo was examined using the murine model of salpingitis in C,H mice.
CHAPTER 2 
Materials and Methods
Materials
Concentrated (lOx) modified Eagle's minimum essential medium (MEM), N-2- 
hydroxyethylpiperazine-N-2'-ethanesulfonic acid (HEPES), glutamine, fetal bovine 
serum (FBS), crystalline penicillin G, nystatin (10,000 U/ml), tissue culture grade 
penicillin/streptomycin (10,000 U/ml penicillin/10,000 /ig/ml streptomycin), 
gentamicin sulfate (50 mg/ml), cycloheximide (CH), Dulbecco’s phosphate buffered 
saline (DPBS), and cortisone acetate (CA) were purchased from Sigma Chemical Co. 
Trypsin-ethylenediaminetetraacetic acid (Trypsin-EDTA) was purchased from Gibco.
Brain heart infusion (BHI), yeast extract, tryptic soy agar, GC agar base, 
MacConkey agar and BHI agar were purchased from Difco. Sheep blood was 
purchased from Brown Laboratory. L-cysteine, vitamin K, and hemin were 
purchased from Sigma Chemical Co. Bio-x was purchased from Scott. Resazurin 
was purchased from Eastman Chemicals. Chopped meat carbohydrate broth (CMC) 
was purchased from Carr-Scarborough.
Ketaset (Aveco) and Rompun (Haver) were purchased from the Division of 
Laboratory Animal Resources (DLAR), James H. Quillen College of Medicine,
ETSU. Depo-Provera (DP), medroxyprogesterone acetate, was generously provided 
by Upjohn.
Taq DNA polymerase and Eco R1 were purchased from Promega.
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Immunofluorescent staining buffer (IFA buffer) was purchased from Zeus Scientific. 
Oligonucleotide primers for polymerase chain reaction (PCR) and an internal 
oligonucleotide probe were synthesized by National Biosciences. Pace 2 CT 
Detection System was purchased from Gen-Probe. Seakem Agarose was purchased 
from the Marine Colloids Division of FMC. Electrophoresis grade ethidium bromide 
was purchased from Fisher Biotech. DNA molecular weight markers were purchased 
from Bio-Rad. Polaroid T-55 film was generously donated by Sigma Chemical Co.
Cells
McCoy cells were a generous gift of Dr. J. Schachtcr, San Francisco, CA.
Media
McCoy cell growth medium was supplemented Ix MEM. For 500 ml growth 
medium, 50 ml lOx MEM was diluted with 450 ml sterile, distilled water. This was 
supplemented with 20 ml 27% glucose, 20 ml 1M HEPES (pH 7.3), 50 ml heat- 
inactivated FBS, 5 ml 7.5% sodium bicarbonate, and 5 ml 200 mM glutamine. Fresh 
glutamine was added every four days of storage. CT permissive medium also 
contained 20 pg/ml gentamicin sulfate (control medium). Nonpermissive medium 
contained penicillin/streptomycin at concentrations indicated in the text (penicillin 
medium). CH medium was McCoy cell growth medium that also contained 
cycloheximide (1 pg/ml). Unless otherwise indicated CH medium was supplemented 
with gentamicin.
BHI broth consisted of: 37 g BHI, 5 g yeast extract, 4 ml resazurin solution, 
0.5 g L-cysteine hydrochloride and 10 ml vitamin Kj-hemin solution per 1000 ml 
broth. Vitamin K|-hemin solution consisted of 5 ml 1.5% vitamin Kj (w/v) in ethanol 
(filter sterilized) mixed into sterile 0.05% aqueous hemin (w/v). Resazurin solution 
was one tablet of resazurin dissolved in 44 ml water. Blood agar plates (BAP) 
consisted of 40 g tryptic soy agar in 1000 ml water. After steam sterilization and 
cooling to approximately 50°C, 60 ml sheep blood was added and the mixture was 
poured into petri dishes and allowed to solidify. Chocolate agar plates (CAP) 
consisted of two separate solutions that were steam sterilized and then mixed. In the 
first solution, 17 g GC agar base was dissolved in 250 ml distilled water. In the 
second solution, 5 g hemoglobin was dissolved in 250 ml distilled water. After 
sterilization, 5 ml Bio-x was added to the complete mixture and the medium was 
poured into petri dishes and allowed to solidify. MacConkey agar plates (MAC) were 
mixed according to the manufacturer's instructions.
By£fers_and_Solutions
Trypsin-EDTA consisted of 0.25% trypsin and 0.53mM EDTA in Hank’s 
balanced salt solution without calcium chloride, magnesium chloride hexahydrate, or 
magnesium sulfate heptahydrate. Transport medium used to collect and store CT 
(2SP) was 0.20 M sucrose in sodium phosphate buffer (0.02 M NaHzP 04 and 0.02 M 
Na2HP04) that was filter sterilized and supplemented with nystatin (25 pg/ml). IFA 
buffer was phosphate buffered saline mixed according to manufacturer’s instructions.
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DPBS consisted of 0.90 mM calcium chloride (anhydrous), 2.68 mM potassium 
chloride, 1.47 mM potassium phosphate monobasic, 0.49 mM magnesium chloride 
hexahydrate, 136.9 mM sodium chloride and 8.06 mM sodium phosphate 
heptahydrate (dibasic).
Tris-Borate-EDTA (TBE) was prepared as a lOx stock solution containing 0.89 
M Tris-borate, 0.89 M boric acid and 0.02 M EDTA. This stock solution was 
diluted to the working solution by a 1:10 dilution with distilled water. Gel Loading 
Buffer was prepared as a lOx stock solution containing 50% glycerol and 0.25% 
bromophenol blue in lx  TBE buffer. Taq DNA polymerase came with a 
commercially prepared lOx buffer that consisted of 500 mM KC1, 100 mM Tris-HCl 
(pH 9.0), 15 mM MgCl2, 0.1% gelatin (w/v) and 1% Triton X-100. Eco R1 came 
with a commercially prepared lOx buffer that consisted of 900 mM Tris-HCl (pH 
7.5), 500 mM NaCl, 100 mM MgCI2 and 1 mg/ml bovine serum albumin.
Monoclonal Antibodies and Stains
An FITC-conjugated monoclonal antibody specific for CT major outer 
membrane protein (MOMP) was purchased from Syva (Microtrak CT Culture 
Confirmation System). An FITC-conjugated monoclonal antibody against the genus- 
specific antigen LPS was purchased from Ortho Scientific (Cultureset Chlamydia 
Detection System).
Jones* iodine consisted of 50 ml 95% ethanol, 5 g iodine, 5 g potassium
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iodide, and 50 ml distilled water, dissolved in that order and filtered through two 
Whatman #1 filters.
Animals
Female mice, strain QH/HeNCRL, were purchased from Charles River 
Laboratories. The mice were housed in isolation in the DLAR, James H. Quillen 
College of Medicine, ETSU, The mice were caged on direct bedding with each cage 
covered with a filter top. A twelve hour light/dark cycle was maintained, with food 
and water dispensed ad libitum.
Methods
Chlamydiae
The strain of CT used was isolated in our clinical laboratory from a 
conjunctival swab obtained from the left eye of a two-week old human female 
suffering from a perinatal infection. Microimmunofluorescence performed by Dr. R. 
Jones' laboratory (University of Indiana) determined this strain to be a serovar D.
The organism has been passaged an indeterminate number of times in McCoy cells 
over the past five years.
The EB suspension used to inoculate McCoy cells and mice was generated by 
harvesting infected McCoy cell monolayers using sterile 4mm beads and vortexing 
each vial 15-20 seconds. The crude lysate from each vial was pooled, dispensed into
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0.5 and 1.0 ml aliquots, and stored at -80°C. The lysate was titrated by inoculation 
of serial dilutions to determine the number of inclusion forming units (IFU) per ml.
McCov CelLCulture
McCoy cells were grown and maintained in 150 cm? tissue culture flasks in 
control medium. Uninfected cells were grown at 37°C in a humidified atmosphere of 
5% C 02. Confluent monolayers were trypsinized, rinsed one time with control 
medium, and counted using a standard hemacytometer. Viability was determined by 
Trypan Blue dye exclusion (Mishell and Shiigi 1980).
CT Culture
The procedure used to culture infectious CT EBs was a modification of the 
technique of Smith (1979). Briefly, freshly trypsinized McCoy cells were diluted to a 
final concentration of 5 x 105 cells/ml in control medium and dispensed into shell 
vials (ashed, 1 dram vials containing 12 mm coverslips), 1 ml per vial. Bach vial 
was closed with a sterile #0 rubber stopper and incubated at 37°C overnight. At time 
of inoculation, medium was aspirated from the monolayers and 100 fil inoculum 
added to each vial. The inoculated vials were centrifuged at 900 x g for 45 minutes, 
ambient temperature. After centrifugation, 1 ml/vial CH medium was added and the 
vials incubated at 37°C for 48-72 hours, at which time the medium was aspirated and 
the coverslips fixed with methanol for 10 minutes. The monolayers were stained with 
Jones' iodine for 30 minutes as described by Smith (1979). The stained coverslips
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were inverted and mounted on a microscope slide with glycerol:Jones* iodine (1:1). 
The inclusions were enumerated after scanning the slide at lOOx magnification. 
Suspected inclusions were confirmed by observation of the proper morphology at 
400x magnification or by staining with FITC-conjugated anti-MOMP.
To increase the sensitivity of CT detection by culture in the in vivo 
experiments, blind passage was employed. Samples from vaginal swabs or tissues 
from the mice were inoculated in duplicate. After 48-72 hours, one replicate was 
stained and screened for inclusions. If the sample appeared negative, the other 
replicate was harvested by vortexing with glass beads, and 100 pi of the lysate was 
inoculated onto a fresh McCoy cell monolayer and cultured as previously described. 
Detection of inclusions in either the primary or the secondary culture was considered 
diagnostic of productive CT infection.
Quantitation of infectious CT was determined by inoculation of serial dilutions 
of harvested lysates using the standard CT culture technique. The number of IFU/ml 
was determined as follows: No. Inclusions x reciprocal dilution x 10 =  IFU/ml.
Yield (the number of IFU recovered per inclusion) was determined as follows:
No. IFU ml'1 /Total No, Inclusions. Multiplicity of infection (MOI) was calculated: 
No. IFU Inoculated/No. Cells.
Immunofluorescent Staining of McCov Ceils
Anti-MOMP. Infected monolayers were stained using the coverslip method,
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according to the manufacturers’ instructions. Cells were fixed with methanol. 
Coverslips were then removed from the vials since staining of the coverslip in the vial 
did not give uniform results. For each coverslip, 30 fd of stain was layered gently on 
top. The slides were incubated at 37°C for 30 minutes in a moist chamber, and 
rinsed by vigorously dipping each coverslip into a beaker of IFA buffer 20 times. 
Coverslips were then blotted and mounted onto a fresh microscope slide. Inclusions 
were observed using a Reichert fluorescent microscope.
It was also possible to restain slides previously stained with iodine. The 
coverslip was placed in 1-2 ml IFA buffer and allowed to rinse at least one hour. If 
heavily stained with iodine, the IFA buffer was changed and the coverslip washed 
until all traces of the iodine were removed. Then the coverslip was stained with anti- 
MOMP as described above.
Anti-LPS. Infected monolayers were stained according to manufacturer’s 
instructions. Briefly, infected monolayers were washed one time with 4ml DPBS per 
vial, then were washed one time with 4 ml cold (4°C) methanol per vial. Coverslips 
were fixed with 4 ml cold methanol for 10 minutes and airdried for 15 minutes.
Dried coverslips were rehydrated by addition of 1 ml DPBS per vial and placed cell- 
side up onto microscope slides. Five drops of anti-LPS were added to each coverslip 
and the slides were incubated for 30 minutes in a moist chamber at room temperature. 
Coverslips were vigorously washed by dipping them into a beaker of IFA buffer and 
were mounted inverted on fresh microscope slides.
26
Effect of Penicillin Pretreatment on CT Infection
Shell vials were seeded with 1 x 105 McCoy cells per vial and incubated 
overnight at 37°C. The control medium was replaced with fresh penicillin medium 
(400 U/ml penicillin and 400 pg/ml streptomycin) 48 hours prior to inoculation in one 
group of 8 vials and at 24 hours prior to inoculation another group of 8 vials.
Normal control cultures were McCoy cells grown in control medium. At the time of 
inoculation, the monolayers were washed twice with prewarmed DPBS and inoculated 
with 200 IFU CT as previously described. After centrifugation, the inoculum was 
removed and quadruplicate vials were fed with either control medium containing CH 
or CH medium containing penicillin/streptomycin (400 U/ml penicillin). The cultures 
were incubated for 48 hours, at which time duplicate cultures were stained with iodine 
or harvested to determine recovery of infectious CT. McCoy cells grown for 2 weeks 
in penicillin medium (400 U/ml) were used in another experiment of the same design.
Effect of Intracellular Levels of Penicillin upon CT Replication
Confluent McCoy cell monolayers in shell vials were mock-inoculated with 
2SP, fed with either control CH medium or CH medium containing 100 U/ml or 400 
U/ml of penicillin/streptomycin and incubated for 48 hours, 37°C. Monolayers were 
washed twice with DPBS (1 ml/vial) and harvested by vortexing with glass beads.
Cell lysates were mixed 1:2 with freshly harvested CT and assayed using the standard 
CT culture. Intracellular inclusion formation was detected by iodine stain.
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Penicillin Dose Curves
McCoy cells (10® cells/vial) were inoculated with CT either at MOI =  2.0 
(2.0 x 10s IFU) or MOI =  0.0003 (3 x 101 IFU) and centrifuged for 45 minutes as 
described for standard CT culture. After centrifugation, inoculum was removed and 
each vial was fed with control CH medium or CH medium containing 
penicillin/streptomycin (selected concentrations of penicillin indicated in Results).
Vials were processed at 52, 73, and 96 hours post-inoculation (p.i.). For each 
timepoint, each group was inoculated in quadruplicate; one pair of vials were stained 
to determine initial inclusion number and morphology, while the other pair of vials 
was harvested to determine recovery of infectious CT, Shell vials without McCoy 
cells were also inoculated in duplicate, refed control CH medium and harvested at 
each timepoint to determine recovery of residual inoculum (glass control).
Detection of CT rRNA
CT rRNA was detected by using the Gen-Probe PACE 2 CT detection system. 
This system employs a chemiluminescently-labelled cDNA probe that hybridizes to 
CT rRNA in a soluble hybridization assay. The sequence and specific site of 
hybridization are proprietary. Culture supernatants and cell lysates were diluted 1:3 
in the extraction buffer provided and assayed according to manufacturer's instructions. 
Level of hybridization was determined by luminometer and reported as relative 
luminescence units (RLU).
UV-Inactivation of CT
CT suspensions were UV-inactivated using a modification of the procedure 
described by Maslow et al. 1988. CT inoculum (1 ml) was placed in a 60 cm petri 
dish and exposed to a 15w germicidal lamp at a distance of 45 cm for 10 minutes. 
UV-inactivated inoculum was rapidly frozen at -80°C and thawed prior to use.
Kinetics of CT Infection In Vitro
The kinedcs of acute CT infecdon in CH-treated McCoy cells and the effect of 
penicillin upon such infecdon was examined. McCoy cell monolayers in shell vials 
were inoculated with 5 x 10* IFU/vial (MOI =  0.05), centrifuged at 900 x g for 45 
minutes and the inoculum was removed. Some vials were fed with control CH 
medium and others were fed with CH medium containing 100 U/ml penicillin. At 
sequential times p.i., duplicate vials from each group were fixed and stained with 
iodine to determine initial inclusion number and morphology and a separate set of 
duplicate vials were harvested to determine yield of infectious CT by culture and level 
of CT rRNA by Pace 2 assay. Two fractions were collected from the vials that were 
harvested: culture supernatants were collected to determine the presence of cell-free 
CT, the monolayers were then washed two times with DPBS (1 ml/vial) and the cells 
were lysed into fresh DPBS (1 ml/vial) to determine level of cell-associated CT. 
Controls for detection of residual inoculum included McCoy cells inoculated with UV- 
inactivated CT and fed with control CH medium to determine levels o f CT rRNA 
from a nonreplicative inoculum, and cell-free shell vials (glass control) that were
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inoculated to determine levels of residual inoculum both by culture and by 
hybridization.
Persistent CT Infection.of McCov Cells
McCoy cells, passage number 67 from liquid nitrogen storage, were 
trypsinized, counted, and 3.6 x 10s cells were placed in each of two 50 ml centrifuge 
tubes. The cells were pelleted and resuspended in 1 ml CT inoculum (1.64 x 10* 
IFU/ml; MOI =  45.6) and centrifuged for 60 minutes at 900 x g, ambient 
temperature. The inoculum was not removed, rather the cells were gently 
resuspended and 17 ml McCoy cell growth medium was added, containing either 
gentamicin (20 pg/ml) (control medium) or penicillin/streptomycin (100 U/ml 
penicillin and 100 pg streptomycin)(penicillin medium). Cultures were plated in 24- 
well dishes at a concentration of 2 x 10* cells/well (1 ml/well) and incubated at 37°C 
in a humidified atmosphere containing 5% COj. Three wells had sterile coverslips 
added to permit standard staining to observe initial inclusion formation. Every 3-5 
days (up to passage number 15 and once a week thereafter) the cells were treated as 
follows : a.) 3 wells were fixed with methanol and stained with iodine, b.) 3 wells 
were washed 2 times with DPBS (lml/well) and the cells were then scraped into 1 
ml/well fresh DPBS and lysed with beads, and c.) the remaining 12 wells were rinsed 
as just described, trypsinized and transferred into fresh plates at a  ratio of 1:3 
(passage number 1-6) or 1:6 (passage number 7-22), Persistently-infected McCoy 
cells (CT-McCoy cells) were placed into growth medium containing different
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antibiotics as indicated in figures 20 through 25 and the text in Chapter 3.
PCR
Preparation of Cell Lvsates for PCR. Cell lysates from one well were 
extracted one time with equilibrated phenokchloroform (Sambrook et al. 1989). One 
tenth volume of 3M sodium acetate was added to the aqueous phase, and then 2.5 
volumes cold absolute ethanol was added to precipitate the DNA. The ethanol 
precipitation reactions were incubated overnight at -20°C and the DNA was pelleted 
by centrifuging at 11,000 x g at 4°C for 30 minutes. The pellets were airdried and 
resuspended in a total of 20 /xl sterile water (tubes were rinsed 2 times with sterile 
water and the suspensions pooled).
Oligonucleotide Primers and Probe. Sequences for oligonucleotide primers 
and an internal probe were obtained from Holland et al. 1990: N terminal sense 
primer (CT1), 5’CCT GTG GGG AAT CCT GCT CAA3’; antisense orientation 
(CT4), 5’GTC GAA AAC AAA GTC A/TCC A/GTA GTA3'; and internal probe 
(CT3), 5’CCA T/CAG AAT TCC GTC GAT CAT3’. The primer pair yielded a 144 
base pair (bp) fragment from a highly conserved region of the CT MOMP gene 
(Holland et al. 1990). The amplified fragment spanned a region containing the site 
for the internal probe as well as an EcoRl cleavage site which yields a diagnostic 103 
bp fragment when cleaved (Holland et al. 1990).
DMA Amplification. PCR was performed on 5 pi DNA extracted from cell 
lysates collected from single wells. Total reaction volume was 50 pi and the final 
reaction mixture contained 0.125 M of each primer (unless otherwise indicated in the 
text); 200 pM  each of dATP, dCTP, dGT,P and T IP; lx Taq DNA polymerase 
buffer and 2.5 U Taq DNA polymerase. Each reaction was overlaid with 20-30 pi 
mineral oil. Samples underwent 40 cycles of amplification in a GTC-1 Genetic 
Thermal Cycler (Precision Scientific). The amplification cycle (modified from 
Holland et al. 1990) consisted of DNA denaturation for 1.5 minutes at 94°C, primer 
annealing to template DNA at 60°C for 1.5 minutes and primer extension at 72°C for 
2 minutes. The positive control was high titer CT inocula and negative controls were 
uninfected McCoy cell lysates and water.
Optimization of.PCR. Lysates from CT-infected McCoy cells were diluted to 
concentrations of 10, 100 and 1000 IFU/reaction. Uninfected McCoy cell lysates 
were mock diluted to the same levels and used as negative controls. Three primer 
concentrations were examined: 0.25 pM, 0.5 pM  and 1.0 pM. Uninfected McCoy 
cell lysates were amplified only with a primer concentration of 0.5 pM. These 
reactions were run in a total reaction volume of 100 pi (see DNA Amplification 
above).
Products from like amplification reactions were pooled and precipitated with 
ethanol. The pelleted DNA was resuspended in 15 /cl water and digested with EcoRI. 
Both digested and undigested samples were resolved on a 1.2% agarose gel.
EcoRI Digestion of Amplified Products
For confirmation that the proper DNA fragment was being generated , 2 pi of 
a positive and negative control were digested with EcoRI (14 U/reaction) in a final 
reaction volume of 20 pi. Samples were added to Ix EcoRI buffer and digested for 
60 minutes at 37°C. Digested and undigested products were elecrophoresed on 1.2% 
agarose gels containing 0.S pg/ml ethidium bromide and photographed (see Gel 
Electrophoresis below).
Gel Electrophoresis
1.2% agarose (w/v) was melted in lx TBE buffer and 0.5 pg/ml ethidium 
bromide added. Horizontal minigels were poured and allowed to solidify. Samples 
were diluted 1:10 in lOx loading buffer, placed in wells and the gels were 
electrophoresed 40-55 minutes at 94-96 volts (Fisher Biotech). Bands were 
illuminated on a UV transilluminator and photographed with Polaroid Type 55 film.
In_Vivo.Inoculation of_CT_in_Mice
Virgin female CjH/HeCRL mice were divided into p re treated and nontreated 
groups containing infected and control animals in each group. Pretreated mice were 
injected subcutaneously in the back of the neck with DP in two doses: one dose (2,5 
mg) seven days prior to inoculation and another dose (2.5 mg) at the time of 
inoculation. The mice were inoculated both intrauterinely and intravaginally with CT
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using a modification of the procedure described by Tuffrey et al. (1986a). Mice were 
anaesthetized by intramuscular (i.m.) injection of 0.07 ml ketaset:rompun:water 
(1:1:1) into a hind leg. Intrauterine inoculation was accomplished by making a lateral 
incision over the right ovarian fot pad and injecting 0.1-0.2 ml of inoculum directly 
into the tip of the uterine horn using a 30g needle and a chilled syringe. The incision 
was sutured. The mice were then inoculated intravaginally by insertion of a blunted 
23g needle into the vagina and injection of 0.05-0.10 ml inoculum. Sequential 
vaginal swabs were collected for the duration of the experiments and cultured with 
blind passage to detect infectious CT. Vaginal swabs were collected using either 
mini-tip culturettes (Marion Scientific) or Pur-Wraps urethral swabs (Hardwood 
Products Co.). Swabs were placed in 0.5 ml 2SP with 4mm sterile glass beads and 
vortexed vigorously 15-20 seconds prior to inoculation into McCoy cells. At 
sequential times p.i., mice were killed by either COj asphyxiation or by cervical 
dislocation, gross examination was performed on the ovaries, fallopian tubes, and 
uterine tissues. Tissue samples of these organs were collected and saved: (a) in 0.5 
ml 2SP for CT culture with blind passage to detect the presence of infectious EBs, 
and (b) in 10% formalin for future histologic examination and/or in silu hybridization. 
Tissue samples for culture were minced and vortexed with glass beads to release 
infectious cells. At the time of sacrifice, peritoneal swabs were obtained and cultured 
to determine if any post-surgical superinfection had occurred. In experiment #080190 
peritoneal swabs were inoculated onto BAP, CAP, and MAC plates and into BHI 
broth. These media were incubated aerobically at 37°C for 48 hours to detect
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presence of any aerobic growth. Swabs were also inoculated onto BAP and into 
CMC broth, and incubated 48 hours under anaerobic conditions to detect any 
anaerobic growth. In experiment #070191 peritoneal swabs were inoculated onto 
BAP cultured under aerobic conditions, and into CMC broth cultured under anaerobic 
conditions.
Experiment 1. Mice were inoculated with 9 x 10s IFU of CT (0.2 ml) 
intrauterinely, and with approximately 2.25 x 10* IFU of CT intravaginally (0.1ml). 
Controls included DP-pretreated and nontreated animals inoculated with uninfected 
McCoy cell lysates. The length of the experiment was 84 days p.i.
Experiment 2. All mice in this experiment were DP-pretreated with the 
exception of six nontreated control mice that did not undergo any type of inoculation. 
Control mice were DP-pretreated and nontreated mice which underwent no inoculation 
procedure at all. All other mice were inoculated with CT both intrauterinely (1.7 x 
109 IFU (0.1 ml)) and intravaginally (8.5 x 10* IFU (0.05 ml). The length of the 
experiment was 22 weeks p.i. One group of CT-inoculated mice (34) were injected 
with 2000 U penicillin G at 9 and 16 days p.i. (2 doses of 1000 U penicillin were 
injected intramuscularly each day). At 10 weeks p.i., 2/3 of the mice which became 
culture-negative for a minimum of 2 weeks were injected with cortisone-acetate (CA) 
or DP subcutaneously in an attempt to reactivate the infection. CA-treated mice were
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injected every other day over a period of 12 days (6 doses, 125 mg/kg per day). DP- 
treated mice were injected with 2.5 mg DP once a week for 2 weeks. CT-inoculated 
mice, from the same subpopulation, injected with saline (following the CA schedule), 
served as control animals. The first reactivation group of mice was killed 15-16 
weeks p.i. At 17 weeks p.i., all other mice (culture-negative for a minimum of 2 
weeks) were subjected to the same steroid induction regimen and were killed at 22 
weeks p.i.
CHAPTER 3 
Results
In Vitro Models
Effect of Penicillin on CT Inclusion Morphology
Penicillin treatment of CT-infected McCoy cells dramatically altered inclusion 
morphology even at concentrations considered subinhibitory (10 U/ml). When stained 
with iodine, penicillin-treated CT-inoculated McCoy cells did not have any normal 
inclusions but did have large vacuoles that appeared to contain little or no glycogen 
(Figure 3A-B). Staining these monolayers with a monoclonal antibody (MAb) against 
CT MOMP demonstrated that this chlamydial antigen was present in these abnormal 
inclusions, although the staining was less intense and the antigen was deposited 
differently than in normal inclusions (Figure 4A-B). The deposition of MOMP in these 
abnormal inclusions resembled large open rings or "bubbles” (Figure 4B). The discrete, 
highly fluorescent particles (elementary bodies) observed in normal inclusions at this time 
p.i. were almost completely absent in the abnormal inclusions. Staining of the penicillin- 
treated, CT-inoculated McCoy cells with a MAb against chlamydial LPS yielded a 
similar result. Chlamydial LPS was present in these abnormal inclusions and was 
deposited in a similar fashion, i.e. "bubbles",
36
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Figure 3
CT-inoculated McCoy cells stained with iodine (40x).
A. Untreated cultures with normal inclusions.
B. Penicillin-treated cultures with abnormal inclusions and vacuoles (some indicated by 
arrows).
Figure 4
CT-inoculated McCoy cells stained with anti-MOMP (lOOx).
A. Untreated cultures with normal inclusions.
B. Penicillin-treated cultures with abnormal inclusions.
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Penicillin J r e treatment of McCov Cells
Penicillin pretreatment of McCoy cells did not affect subsequent CT replication 
provided that the penicillin was removed and monolayers were washed prior to 
inoculation. Neither initial inclusion formation (number and morphology) nor yield of 
infectious CT were altered by penicillin pretreatment of the monolayers (Figure 3). Even 
cells grown for two weeks in medium containing 400 U/ml penicillin supported CT 
replication provided that the monolayers were washed prior to inoculation (Figure 6). 
Intracellular levels of penicillin did not appear to inhibit CT replication as lysates from 
uninfected McCoy cells grown in 100 or 400 U/ml penicillin (washed prior to lysis) did 
not inhibit inclusion formation, as compared to control cultures (Figure 7).
Penicillin _Dose_Curves
In order to determine if the effect of penicillin upon CT infection was dose 
dependent, a range of penicillin concentrations were tested and compared to control 
cultures. The parameters examined were initial inclusion formation and yield of 
infectious CT. The penicillin concentrations examined were 10 U/ml, SO U/ml, 100 
U/ml and 200 U/ml. These concentrations bracketed a reported MIC value of 16 to >64 
U (Lee et al. 1978). When stained with anti-MOMP, the number of abnormal inclusions 
in the penicillin-treated CT cultures did not differ substantially from the number of 
normal inclusions found in cultures grown in CT-permissive medium (Figure 8). A 
similar result was observed when penicillin-treated CT cultures were stained with anti- 
LPS (Figure 9). Comparable numbers of inclusions were detected using anti-MOMP or
Figure 5 40
Effect of penicillin pretreatment of McCoy cells upon subsequent CT replication.
OH, 24H and 48H represent the hours of penicillin pretreatment prior to CT 
inoculation. C represents control medium placed on the cultures after inoculation. P 
represents penicillin medium placed on the cultures after inoculation.
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Effect of penicillin pretreatment of McCoy cells for two weeks prior to inoculation 
upon subsequent CT replication.
CCC =  Control culture
PPG =  Penicillin pretreatment for 2 weeks; control medium p.i.
PCC =  Penicillin pretreatment for 2 weeks; control medium -48 hours;
control medium p.i.
CCP -  Control medium; penicillin medium p.i.
PPP -  Penicillin pretreatment for 2 weeks; penicillin medium p.i.
PCP =  Penicillin pretreatment for 2 weeks; control -48 hours; penicillin 
medium p.i.
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Figure 7
Effect of intracellular levels of penicillin upon CT replication.
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Effect of different doses of penicillin upon intracellular inclusion formation in CT- 
infected McCoy cells stained with anti-MOMP.
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Effect of different doses of penicillin upon intracellular inclusion formation in CT- 
infected McCoy cells stained with anti-LPS.
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anti-LPS (Figure 9). This result was observed over the range of penicillin concentrations 
tested. Initial inclusion formation was not dose dependent over the range tested since 
similar results were seen whether 10 U/ml or 200 U/ml penicillin were added. Addition 
of penicillin at the time of inoculation did not inhibit initial inclusion formation. 
However, addition of penicillin to CT cultures did drastically reduce the yield of 
infectious CT from these cells. When an MOI of 2.0 was used, the number of IFU 
recovered from penicillin-treated CT cultures was reduced greater than 1,000,000-fold 
(Figure 10). This reduction was observed over the range of penicillin concentrations 
tested and was not dose-dependent (Figure 11). When an MOI of 0,0003 was used, no 
IFU were recovered from penicillin-treated CT cultures at any penicillin concentration 
tested, although abnormal initial inclusions were observed (Table 1 and Figure 12). With 
a sufficiently large inoculum (i.e. high MOI), penicillin did not completely inhibit CT 
replication, although infectious elementary body production was dramatically reduced.
Effect of Fenicillin upon the Kinetics of Acute CT Infection
Although little or no infectious CT was produced in penicillin-treated cultures, it 
remained possible that noninfectious reticulate bodies or defective elementary bodies were 
present. Culture would not detect either of these forms. A cDNA probe specific for CT 
rRNA was employed to detect CT in tissue culture supernatants or cell lysates. A 
standard curve comparing IFU to RLU was performed using the probe assay (Figure 13). 
Linear regression analysis showed that 1 IFU corresponded to 53 RLU. However, this 
value was equal to or less than the nonspecific background detected when negative
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Figure 10
Effect of penicillin upon the yield of infectious CT (MOI =  2.0).
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Effect of penicillin upon recovery of infectious CT (MOI -  2.0).
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Table 1 Intracellular Inclusion Formation and CT Recovery from McCoy Cells 
Inoculated with CT In Varying Penicillin Concentrations (MOI »  0,0003)
Dose
Penicillin
(U/ml)
Time p.i. 
0>)
Initial Inclusions A
Recovery A 
(IFU/ml)No. Ij Type* No. MOMP Type
0 52 258 N 214 N 550
10 0.5 S 75 I 0
50 0 76 I 0
100 0 92 I 0
200 0 • 52 I 0
0 73 200 ' N 155 N 1.3 x 10*
10 • 0.5 S 72 I 0
.50 34 I 0
100 74 I . o
200 47 I 0
0 95 94 N 202* N 1.1 X 10*
10 0 14* I 050 0 27 I ’ 0 •100 0 37 I o
200 0 ' 28 I 0
A All values are except where marked •
* Ineluiion morpholojy: N ■ Normal; S *• Small but complete; I ■■ Incomplete
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Figure 12
Effect of penicillin upon the yield of infectious CT (MOI -  0.0003).
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Figure 13
Standard curve comparing inclusion forming units to relative luminescence units.
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control nucleic acid was assayed. Therefore, the assay cutoff value chosen was 1.5 times 
the mean of the triplicate negative controls and was consistently greater than the highest 
of the negatives. The probe assay was very sensitive when thus employed and detected 
as few as 5 IFU (Figure 13). The probe assay also could detect UV-inactivated CT with 
the same sensitivity (Figure 14). The probe assay was more sensitive than culture as CT 
does not need to be viable or infectious to be detected-by the former. Reticulate bodies 
and nonviable or defective elementary bodies could be detected using this technique. A 
kinetic study of acute CT infection in CH-treated McCoy cells was performed which 
employed both culture and probe assay. Initial inclusion formation was as observed 
previously. Residual inoculum was not detectable by culture in either fraction of the 
glass control by 15 hours p.i. Infectious CT was not recovered from any culture 
inoculated with UV-inactivated CT. CT culture of supernatants from penicillin-treated 
cultures was not performed as the penicillin in the medium would interfere with accurate 
quantitation of infectious CT. Recovery of IFU from supernatants of untreated cultures 
exhibited a typical growth curve with the minimum at 15 hours p.i. (305 IFU), and 
rapidly increasing to a maximum number of 7.1 x 10s IFU/ml at 73 hours p.i. (Figure 
15A). A similar growth curve was observed when cell lysates from untreated cultures 
were assayed for infectious CT (Figure 15B). The growth curve obtained from the cell 
lysates of penicillin-treated CT cultures was quite different from that of the control with 
a single peak of IFU produced at 32 hours p.i. (80 IFU/ml). Recovery gradually 
decreased until no IFU were recovered at 98 hours p.i. (Figure 15B). It was not possible 
to determine if this small peak of IFU production reflected abortive replication or that
Figure 14 .
Comparison of standard curves generated by using viable and UV-inactivated CT,
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Figure 15
Kinetics o f the recovery of infectious CT from CT-inoculated McCoy cells in the 
presence and absence of penicillin (100 U/ml).
A. Cell-free IFU.
B. Cell-associated IFU.
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CT did not become inactivated as quickly in the presence of cells, i.e. residual inoculum.
Both culture supernatants and cell lysates from control and penicillin-treated CT 
cultures were assayed by DNA-rRNA hybridization (Figure 16). CT rRNA was detected 
in the supernatants of control cultures in increasing amounts from 25 hours p.i. onward 
(Figure 16A). This rRNA reflected release of CT elementary bodies into the supernatant 
and/or release of reticulate bodies into the medium due to cell lysis. CT rRNA was 
detected in the supernatants of penicillin-treated CT cultures throughout the course of the 
experiment although at lower concentrations than observed in untreated CT-infected 
cultures (Figure 16A). There was a peak of hybridization at 32 hours p.i. (6,307 RLU) 
gradually declining by 98 hours p.i. to a value of 1,684 RLU which was still 
unequivocally positive (Figure 16A). Both CT-inoculated cell-free shell vials and McCoy 
cells inoculated with UV-inactivated CT were positive by probe assay throughout the time 
range examined, but these controls showed no evidence of CT replication as the values 
remained the same or decreased over time (Figure 16A). These controls were included 
as a measurement of CT rRNA in residual inoculum. The penicillin-treated CT cultures 
produced levels of hybridization far greater than these controls yet significantly less than 
the levels found from supernatants of CT-infected control normal cultures (Figure 16A), 
As with CT rRNA detected in the supernatants of control cultures the CT rRNA from 
the penicillin-treated cultures could represent CT elementary bodies released into the 
culture fluids and/or reticulate bodies from lysed cells. Since culture was not performed 
on the supernatants from penicillin-treated cultures, it was not possible to determine if 
the CT released into the supernatant was infectious. Defective elementary
Figure 16
Kinetics of the levels of CT rRNA in CT-inocuIated McCoy cells in the presence and 
absence of penicillin (100 U/ml).
A. Cell-free RLU.
B. Cell-associated RLU.
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body production was neither proved nor disproved by these results.
Cell-associated CT rRNA was detected by hybridization in lysates of untreated 
and penicillin-treated CT cell cultures (Figure 16B). The levels of CT rRNA detected 
in untreated and penicillin-treated cultures were essentially the same during the first 10 
hours p.i. (Figure 16B). By 15 hours p.i., the level of CT rRNA in penicillin-treated 
cultures was only half that detected in untreated CT-infected control cultures (Figure 
16B). This divergence continued until the level of CT rRNA from penicillin-treated 
cultures peaked at 25 hours p.i. and then declined rapidly (compared to the level found 
in untreated CT cultures). However, the level remained significantly higher than the 
levels of CT rRNA observed in UV-inactivated CT cultures and the glass control.
Cell-associated CT recovery from untreated cultures showed the expected decrease 
(eclipse) in early hours of infection as infectious elementary bodies matured into 
noninfectious reticulate bodies (Figure 17A). That this decrease in infectivity reflected 
maturation of EB into RB was supported further by the dramatic increase in the amount 
of CT rRNA detected by probe assay, particularly between 2 and 25 hours p.i. The 
rapid expansion of the CT rRNA pool was followed by a three log increase in infectious 
CT (Figure 17A). A similar trend was observed when cell-associated CT rRNA and CT 
recovery from penicillin-treated cultures were compared (Figure 17B). There was a 
marked decrease in the number of infectious CT in the early hours of the infection, while 
the amount of CT rRNA dramatically increased until it peaked at 25 hours p.i. (Figure 
17B). The small peak of CT recovery at 32 hours p.i. temporally followed the peak of 
CT rRNA, as was observed in untreated cultures (Figure 17A-B). However, unlike
Figure 17
Comparison of the kinetics of recovery of infectious CT to levels of CT rRNA.
A. Control cultures.
B. Penicillin-treated cultures (100 U/ml).
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untreated cultures, CT recovery and the levels of CT rRNA from penicillin-treated 
cultures decreased over time. At 98 hours p.i., the levels of CT rRNA remained positive 
although CT recovery became undetectable (Figure 17B). .
Optimization of PCR
All DNA amplification reactions from CT-infected cell lysates exhibited a band 
at 144 bp. This band was clearly visible at all dilutions of CT and at all primer 
concentrations tested. Only a primer band at the gel front was visible from amplification 
reactions that contained DNA from uninfected McCoy cells. Intensity of bands was not 
dependent upon primer concentration in the range examined. EcoRI digestion of pooled 
products confirmed the specificity of the fragment as a diagnostic 103 bp band was 
generated from CT-positive amplification reactions (Figure 18). This 103 bp band was 
not detected in amplification reactions from uninfected McCoy cells (Figure 18). For 
further confirmation of the specificity of this reaction, a southern blot was performed 
using the internal probe. Hybridization with the 144 bp fragment was observed. Since 
further experimentation demonstrated that a primer concentration of 0.125 nM was as 
effective as 0.25 pM, the former concentration was used in all subsequent PCR reactions 
(Figure 19).
Development of CT Persistent!v-infected McCov Cells
Freshly trypsinized McCoy cells were inoculated with CT in suspension and
Figure 18 59
ECORI DIGESTION OF DNA AMPLIFICATION REACTIONS USING CT- 
INFECTED McCOY CELL LYSATES AND UNINFECTED McCOY CELL 
LYSATES. Lane 1 is molecular weight markers. Lane 2 is undigested DNA 
amplified from CT-infected McCoy cells. Lane 3 is digested DNA amplified from 
CT-infected McCoy cells. Lane 4 is undigested DNA amplified from uninfected 
McCoy cells. Lane 5 is digested DNA amplified from uninfected McCoy cells.
Arrow indicates 144 bp band. Arrowhead indicates 103 bp band.
Figure 19 60
TITRATION OF PRIMER CONCENTRATIONS AGAINST TWO DIFFERENT 
CONCENTRATIONS OF DNA TO OPTIMIZE PCR CONDITIONS. Lane 1 is 
molecular weight markers. Lanes 2 through 4 contained 5 p\ DNA per reaction.
Lane 2 had a primer concentration of 0.25 pM. Lane 3, 0.125 pM. Lane 4, 0.0625 
pM. Lane 5, 0.03125 pM, Lanes 6  through 9 contained 2 p\ DNA per reaction. 
Lane 6 had a primer concentration of 0.25 #tM. Lane &, 0.125 pM. Lane 8 , 0.0625 
pM. Lane 9, 0.03125 pM. Lane 9 was the water negative control.
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planted in 24-well plates. This primary inoculation was designated as passage 0 (PO). 
Each subsequent passage was designated sequentially in the same fashion. Three cell 
lines initiated were: (a) an inoculum of live CT, grown in control medium, (b) an 
inoculum of live CT, grown in penicillin medium and (c) an inoculum of CT, partially 
inactivated by UV treatment, grown in control medium. At each subsequent passage, 
these initial cell lines were placed in either control medium or penicillin medium as 
indicated. Two lineages of. CT-McCoy cells were produced: the penicillin lineage, 
initially inoculated in penicillin medium and the control lineage, initially inoculated in 
control medium. The cells inoculated with UV-treated CT were maintained in control 
medium and formed a separate line (UV-CT-McCoy cells). Only results from the 
penicillin lineage will be presented in detail.
Penicillin Lineage. The penicillin line of CT-McCoy cells was maintained only 
in penicillin medium. This cell line was designated PEN. After inoculation during PO, 
no additional CT was added to this cell line. In the initial passage, a mean of 2581 
abnormal intracellular inclusions was detected by iodine stain (Figure 20). These 
inclusions had the incomplete morphology seen in earlier experiments and pronounced 
vacuolization of the monolayers was observed. These incomplete inclusions stained with 
anti-MOMP in the same pattern seen in earlier experiments. During subsequent passages 
an occasional very small iodine-staining inclusion was observed, but overall, intracellular 
inclusion formation was not observed while the cells were maintained in penicillin 
medium (Figure 20). CT recovery from this cell line rapidly decreased from 40 IFU/ml
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Kinetics of intracellular inclusion formation, recovery of infectious CT and levels of
CT rRNA in the PEN cell line.
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(PO) to 3 IFU/ml (PI) and was not detected in subsequent passages (Figure 20). CT 
rRNA was detectable in passages 0-2 and at very low levels in passages 20-22, but was 
undetectable during intermediate passages (Figure 20). The slight increase in rRNA at 
passages 20-22 was unexpected and the significance of this has not yet been determined.
After the initial passage in penicillin medium, one fraction of cells from the 
penicillin lineage was cultivated thereafter in control medium. This cell line was 
designated PENt and was maintained in control medium. Intracellular inclusion 
formation was zero at P I. However, normal iodine-staining inclusions developed in 
subsequent passages (Figure 21). In contrast to the PEN line, CT recovery from PENt 
persisted throughout the experiment (Figure 21). Therefore, presence of penicillin only 
during the initial passage did not prevent CT replication in subsequent passages.
These results were in contrast to results from other cell lines developed from this 
lineage. CT-McCoy cells grown in the presence of penicillin for 3, 6 , 10, or 18 
passages before subsequent cultivation in control medium. These cell lines were 
designated PEN3l PEN(, PENt0, and PENl(, respectively, for the number of passages the 
cells were maintained in penicillin medium prior to cultivation in control medium for all 
subsequent passages. The PEN3 and PENS lines were initially negative by intracellular 
inclusion formation, recovery of infectious CT and detection of CT rRNA. However, 
PEN) and PEN6 "recovered" to resume productive CT infection after subsequent 
cultivation in penicillin-free medium. PEN3 did not exhibit intracellular inclusion 
formation for three passages after placement in control medium, but then developed 
normal iodine staining inclusions. Intracellular inclusions appeared in PEN3 at passage
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Figure 21
Kinetics of intracellular inclusion formation and recovery of infectious CT in the 
PEN, cell line.
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6 , and infectious CT was produced at passage 5 (Figure 22). CT rRNA was detectable 
at very low levels during passages 4 and 5, then became negative until passages 10-12, 
when CT rRNA increased to levels normally detected during active infection (Figure 22). 
PEN6 recovered more rapidly than PEN3, PENfi developed intracellular.inclusions and 
produced infectious CT immediately after cultivation in control medium (Figure 23). 
The levels of CT rRNA in PEN6 rapidly increased and peaked at more than 500,000 
RLU by passage 11 (Figure 23).
CT-McCoy cells grown in penicillin medium for 10 or 18 passages prior to 
placement in control medium reacted differently than PEN|, PEN3 or PEN(. PENI0 
exhibited low numbers of very small iodine-staining inclusions from passages 12-20 
(Figure 24). Cells on coverslips from passages 13-20 were destained and restained with 
anti-MOMP. CT MOMP could be detected in these monolayers which indicated that this 
protein was being expressed. The inclusions tended to be very small and pleomorphic, 
some had the appearance of complete inclusions and others had the vacuolated ("bubble") 
appearance of the incomplete inclusions described earlier. No infectious CT was 
recovered from these cultures even when inclusions were detected in passages 12-20 
(Figure 24). Very low levels of CT rRNA were detected after cultivation in control 
medium, but these levels did not approach the levels seen during active infection (Figure
24). By the parameters examined, PEN10 appeared to be a true persistent infection, but 
it is unknown whether or not further passages would result in spontaneous reactivation 
and productive infection. PENlt did not exhibit inclusion formation after cultivation in 
control medium nor was infectious CT recovered (Figure 25). Very low levels of CT
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Kinetics of intracellular inclusion formation, recovery of infectious CT and levels of
CT rRNA in the PEN3 cell line.
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Figure 23 I
Kinetics of intracellular inclusion formation, recovery of infectious CT and levels of
CT rRNA in the PENa cell line.
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Figure 24 68
Kinetics of intracellular inclusion formation, recovery of infectious CT and levels of
CT rRNA in the PEN10 cell line.
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Kinetics of intracellular inclusion formation, recovery of infectious CT and levels of
CT rRNA in the PEN,, cell line.
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rRNA were detected in passages 18 and 19, but none was detected in passage 20 (Figure
25). As with PEN10 it is unknown whether or not further culture in control medium 
would have resulted in spontaneous conversion to a productive infection.
Since continued culture in the presence of a microbiostatic antibiotic may favor 
selection of resistant strains, it was necessary to determine if such a selection had 
occurred in this experiment. The PEN) cell line was cultivated for 12 passages in the 
absence of penicillin, after which penicillin was replaced in the culture medium. 
Intracellular inclusion formation was dramatically inhibited (1 iodine-staining inclusion) 
in the next two passages. CT recovery decreased from 3,7 x 10® IFU/ml to 0 IFU/ml 
in passages 13 and 14 (i.e. immediately after penicillin was replaced in the culture 
medium). Also the level of CT rRNA decreased from 9017 RLU (P12) to 110 RLU 
after cultivation in penicillin medium. As further evidence that this strain of CT was still 
sensitive to penicillin, and-MOMP staining of these monolayers demonstrated the 
incomplete inclusions seen in earlier experiments. Therefore, the change from persistent 
to productive infection observed in PEN,, PEN3, and PENS was not due to selection of 
resistant strains of CT, but rather to reactivation of persistent forms.
The observation that penicillin-maintained CT-McCoy cell lines can progress from 
persistent to productive infection suggested that these cells may harbor the chlamydial 
genome in a latent form since expression was not detected by inclusion formation, 
recovery of infectious CT, or CT rRNA. PCR seemed an ideal tool to examine this 
hypothesis. Cell lysates from a single well of each passage of the PEN line of CT- 
McCoy cells were extracted with phenol/chloroform and ethanol-precipitated to isolate
the DNA. The DNA collected from these extractions underwent PCR using a primer 
pair that amplifies a 144 bp region in the CT MOMP gene. The chlamydial genome, or 
at least a portion thereof, was present in all passages of the penicillin line of CT-McCoy 
cells through passage IS (Figures 26 and 27). The genome was not detected in passage 
16, yet was demonstrated (faint band) in passages 17, 18, and 19 (Figures 27 and 28), 
The fact that the specific region was not detected in passage 16 but was evident in 
passages 17-19 may be explained by the fact that DNA from single culture wells was 
amplified. Cells from the other wells were used for inclusion staining, CT recovery, 
rRNA determination and continued cultivation. Unless replication allowed progeny or 
elementary bodies to be distributed to both daughter cells, the cells harboring the CT 
genome would be diluted slowly, such that one aliquot of cells may contain persistently 
infected cells while another would not. The fact that dilution appeared to occur 
suggested that the level of replication in these persistently infected cells was very low and 
that inclusions may not be transmitted to both daughter cells upon division. The 
detection of CT DNA in the PEN line further supports the idea that the change from 
"latent" to productive infection observed in PEN], PEN3f and PENfi reflected reactivation 
of persistent CT infection.
Comparison of the different cell lines of the penicillin lineage of CT-McCoy cell 
lines revealed two patterns. In the first, three cell lines (PENt, PEN3, and PENj) 
converted to a productive infection developing high numbers of intracellular inclusions 
(Figure 29). A pattern of cycling was observed with some cell lines (Figure 29). For 
example, at passage 15, the PEN6 monolayer began to deteriorate which resulted in the
Figure 26 72
AMPLIFICATION REACTIONS USING DNA FROM THE PEN CELL LINE.
Lanes 1 and 10 are molecular weight markers. Lanes 2 through 9 are amplification 
reactions using DNA from sequential passages of the PEN cell line. Lane 2, passage 
1. Lane 3, passage 2. Lane 4, passage 3. Lane 5, passage 4. Lane 6 , passage S. 
Lane 7, passage 6 . Lane 8 , passage 7. Lane 9, passage 8 . Lane 11 is the positive 
control. Lane 13 is the negative control. Lane 14 is the water negative control. 
Arrow indicates position of 144 bp band.
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Figure 27
AMPLIFICATION REACTIONS USING DNA FROM THE PEN CELL LINE.
Lanes 1,6, 11 and 16 are molecular weight markers. Lane 2 is the water negative 
control. Lane 3 is the negative control. Lane 4 is the positive control. Lanes 5 
through 13 are amplification reactions using DNA from sequential passages of the 
PEN cell line. Lane 5, passage 9. Lane 7, passage 10 Lane 8 , passage 11. Lane 9, 
passage 12. Lane 10, passage 13. Lane 12, passage 14. Lane 13, passage 15. Lane 
14, passage 16. Lane 15, passage 17. Lanes 16 through 23 contain products of an 
ECORI digestion of positive and negative controls. Lane 16 is a molecular weight 
marker. Lane 17 is undigested water negative control. Lane 18 is digested water 
negative control. Lane 19 is undigested negative control. Lane 20 is digested 
negative control. Lane 21 is undigested positive control. Lane 22 is digested positive 
control. Lane 23 is digested pGEM-ILl as a positive control for activity of the 
enzyme. Arrows indicates posidon of 144 bp band. Arrowhead indicates position of 
the 103 bp band.

Figure 28 74
AMPLIFICATION REACTIONS USING DNA FROM THE PEN CELL LINE.
Lane 1 is molecular weight markers. Lane 2 is the positive control. Lane 3 is the 
water negative control. Lane 4 is the negative control. Lanes 5 through 7 are 
amplification reactions using DNA from sequential passages of the PEN cell line.
Lane 5, passage 18. Lane 6 , passage 19. Lane 7, passage 20. Arrow indicates 
position of 144 bp band.
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Figure 29
Comparison of the kinetics of intracellular inclusion formation in the penicillin
lineage.
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"apparent" disappearance of intracellular inclusions. Further cultivation resulted in 
regeneration of the monolayers and then another cycle of destruction occurred. In the 
second pattern, PEN|0 began to produce low levels of intracellular inclusions (Figure 29) 
but these levels remained low and the inclusions tended to be very small. Neither PEN,0 
nor PEN,, produced infectious CT (Figure 30) during the time studied, although both 
lines exhibited very low levels of CT rRNA (Figures 31). The very low levels of CT 
rRNA detected in PEN,0 and PEN,, were at the threshold of detection and do not 
compare to the rapidly increasing levels of CT rRNA found in PENj and PEN, (Figure 
31). Further work is required to determine if these cell lines could be reactivated by 
continued culture or by treatment with hormones or cytokines. These cell lines may 
prove to be the best model to study the mechanism(s) underlying CT persistence and 
reactivation.
Control Lineage. CT persistently-infected McCoy cell lines were produced 
without the use of penicillin. McCoy cells inoculated with a high MOI remained healthy 
and viable for several passages but would then undergo a cycle of destruction with lysis 
of most of the monolayer. Further cultivation in fresh medium allowed the monolayers 
to become healthy again, only to undergo another cycle of CPE in subsequent passages. 
By passage 11, a stable productive infection was established and was maintained for an 
extended period of time. UV-treatment of CT allowed for inoculation of McCoy cells 
with a  very low MOI (MOI =  9 x 104). Inoculation of the cells with a low MOI 
allowed a stable productive infection to be established without destruction of the
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Figure 30
Comparison of the kinetics of infectious CT production in the penicillin lineage.
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Figure 31 78
Comparison of the kinetics of the levels of CT rRNA from the different cell lines of 
the penicillin lineage.
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monolayer. It was interesting to note that the UV-CT-McCoy cells were negative by all 
parameters examined for the first few passages, but began to develop intracellular 
inclusions and infectious CT in subsequent passages. Control CT-McCoy cells and UV- 
CT-McCoy cells warrant further examination as examples of persistent CT infection 
established without the use of an antibiotic.
In Vivo Models
Experiment 1
Virgin female C3H mice were preheated with DP or remained untreated 
prior to inoculation with CT or mock-inoculation with uninfected McCoy cell lysate. 
After inoculation, vaginal swabs from CT-infected mice were collected sequentially and 
cultured for infectious CT. CT-inoculated mice which had not been pretreated with DP 
transiently shed CT vaginally, although 50% of these inoculated mice harbored CT in the 
upper tract (Table 2). A more detailed depiction of CT recovery from these mice is 
shown in Table 3. One mouse, sacrificed on day 43 p.i., had not shed CT vaginally for 
33 days, yet infectious CT was isolated from the inoculated uterine horn. Table 3 shows 
that one animal sacrificed on day 15 p.i. had ceased to shed CT vaginally yet infectious 
CT was isolated from six tissues of the upper tract (inoculated and uninoculated sides). 
Therefore, a negative vaginal swab did not correlate with elimination of CT from the 
upper tract. Gross pathology noted in the nontreated CT-inoculated mice included
Table 2
CT Culture of Vaginal Swabs Collected Sequentially from CT-Inoculated Mice
(No DP-Pretieatment)
DAYS POST-INOCULATION*
CT FROM UPPER CROSS |
MOUSE
_ _ N O -
2 7 10 13 15 20 24 29 34 38 41 43
TRACT PATHOLOGY1
1*1 NO ND
1*2 — + + —  — YES ND
. 1*3 — — — + — YES ND
1-4 NO YES(H)
1-5 — — — 111111+1+ NO YES(BH;++)
1*6 • YES YES(H;++)
* + — CT isolated from vaginal swab.
— CT was NOT isolated from vaginal swab.
-
CT was not isolited from any of the mock-inoculated animals at either 2 days p.i. or at time of sacrifice.
* H •=■ Hydrosalpinx. BH “  Bilateral Hydrosalpingcs.
+ -+ +  + +  ™ Increasing severity of erythema. ND ** Not Detected.
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Tabic 3 CT Isolation From Upper Tract Tissues of CT-inoculated Mice 
(No DP-Pretrcatment)
Animal
No.
Days
P J.
Inoculated Side Uninoculated Side
UB
Ovary Tube Horn Ovary Tube Horn
1-1 15
1-2 15 — — — — + + —
1-3 15 — + + + + + +
1-4 43
1-5 43
1-6 43 + *—-
+  =  CT was isolated from the tissue.
— m CT was NOT isolated from the tissue. 
UB= Uterine Body.
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hydrosalpinx formation and erythema (Table 2). Isolation of CT from the upper tract did 
not correlate with detectable presence or absence of gross pathology. Some mice that 
were positive for CT did not have detectable gross pathology, while other mice, which 
exhibited gross pathologic damage, did not seem to harbor CT (Table 2). 
Histopathologic examination of the tissues from these mice has not yet been completed, 
but should reveal whether or not damage at the microscopic level had occurred in 
untreated CT-inoculated mice.
In contrast, DP-pretreated CT-inoculated mice exhibited more extensive vaginal 
CT colonization, as CT was recovered with greater frequency from successive vaginal 
cultures (Table 4). A number of these mice underwent recurrent vaginal shedding of CT 
0 2  successive negative vaginal cultures followed by a positive culture). In fact 58% 
of the DP-pretreated CT-inoculated mice sacrificed at later times (43 and 84 days p.i.) 
underwent recurrent vaginal shedding of CT. Post-surgical adhesions were noted 
frequently in both mock-inoculated and CT-inoculated mice, yet hydrosalpinx formation, 
erythema and enlarged fallopian tubes were found only in CT-inoculated mice and were 
scored as CT-specific gross pathology. In the DP-pretreated CT-inoculated mice, 73,3% 
of the mice exhibited detectable gross pathology at the time of sacrifice (Table 4). Of 
the 3 mice sacrificed at day 84 p.i., one had a hydrosalpinx in the absence of detectable 
CT in vaginal secretions and upper tract (Table 4). Histologic examination of the tissues 
from these mice has not yet been completed, but should reveal the presence and type of 
damage that might have occurred at the microscopic level.
Early in the infection (15 days p.i.) only 2/12 DP-pretreated mice exhibited
Table 4 CT Culture of Vaginal Swabs Collected Sequentially From CT-Inoculated Mice (DP-Pretreated)
B DAYS POST-INOCULATION*
CT FROM GROSS
PATHOLOGY*B MOUSE 1 NO. 2 7 10 13 15 20 24 29 34 38 41 43 45 49 52 55-84
UPPER
TRACT
|  3-3 + + YES ND 1
I 3~* + + YES ND |I 3-9 + + YES ' YES(H;+ +  +) |
2-2 + + — + — YES YES(H;+) B
2-3 + — — — — YES YES(E) |
2-4 + + + 4- + YES YES(E;+) |
2 -t + 4- — + +  —  + 4- YES Y ES(H ;++) |
2-5 + + — — —  4 - + + YES Y E S (+ 4)
2-6 + + + — —  4 - 4 - 4- YES YES(BH;+4*+)
3-2 + + 4- + —  —  — +  — 4* 4- + YES YES(+)
3-5 + 4- + + 4- + YES YES(BH;+)
3-6 + + 4- 4- —  —  _ +  — + + — YES YES(H)
3-1 + + + 4- —  4 - 4 - +  — ' NO ND
3-7 + + + +  —  —  —  — NO ND [
3-8 + + — + + + + + + +
. 
1 NO YES(H) I
A + “  CT isolated from vaginal swab. — “  CT was NOT isolated from vaginal swab.
CT was not isolated from any of the mode-inoculated animals at either 2 days p.i. or at lime of sacrifice,
* H — Hydrosalpinx. BH ** Bilateral Hydrosalpinges. E »  Enlarged Fallopian Tubes. ND “  Not Detected. 
+ - + + +  + *» Increasing severity oF erythema.
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vaginal shedding of CT. Of the three mice sacrificed at this time, none yielded a 
positive vaginal culture, yet all three harbored CT in multiple tissues of the upper tract 
(Tables 4 and 5). This supported previous findings that a negative vaginal culture did 
not correlate with elimination of CT from the upper tract. CT was not isolated from 
vaginal secretions or from upper tract tissues of three mice sacrificed at 84 days p.i. 
(Table 4). It has not yet been determined if these mice harbored CT in a form of 
persistent infection undetectable by culture. In fact, if the different patterns of vaginal 
shedding of CT were compared to isolation of CT from the upper tract, four main motifs 
were possible; a.) CT isolation from upper tract tissuefs) and vaginal secretions, b.) CT 
isolation from the vagina but not from tissue(s) of the upper tract, c.) CT isolation from 
the tissue(s) of the upper tract but not from the vagina and d.) CT isolation from neither 
vaginal secretions nor from tissue(s) of the upper tract. Three of these motifs were 
observed (Table 6A). No CT-inoculated mice had a positive vaginal culture without 
isolation of CT from tissue(s) of the upper tract. If all time points in the experimental 
design were considered, 28.6% of the mice had a "persistent" infection, i.e. negative by 
vaginal culture yet harboring CT in the upper tract (Table 6A). If  only the time points 
2 , 4, and 6 weeks p.i. were considered 33.3% of the mice harbored a "persistent" 
infection (Table 6B). DP-pre treatment enhanced vaginal shedding of CT. However, 
50% of nontreated mice had a "persistent" infection (Tables 6A and 6B). This was in 
contrast to DP-pretreated CT-inoculated mice of which only 20% had a "persistent" 
infection (Table 6A). According to these results, a valuable model to study persistent 
infection would be CT inoculation of mice that had not been pretreated with DP, with
Table 5 CT Isolation From Upper Tract Tissues of CT-inoculated Mice
(DP*Pre treated)
Animal Days
P.I.
Inoculated Side Uninoculatcd Side
No. Ovary Tube Horn Ovary Tube Horn
- UB
3-3 7 + + + _ _ _ +
3-4 7 + + + — + + +
3*9 7 — — + — + — +
2-2 15 — + + — — + —
2-3 15 — + + — + + +
2-4. 15 — + + — + + —
2-1 29 — — + — — + * +
2-5 29 — — _ — + + +
2-6 29 + — + + — + +
3-2 43 — — — — + —
3-5 43 + —
3-6 43 — + — — — — —
3-1 84
3-7 84
3-8 84
+  -  CT was isolated from the tissue.
— «  CT was NOT isolated from the tissue. 
UB= Uterine Body.
86
Table 6  Evidence for Persistent Chlamydial infection of CjH Mice
A
CT Recovery* Number of Mice
Vaginal Upper Tract ProgesteronePretreatment
No
Pretreatment Total
YES YES 9 0 - 9
YES NO 0 0 0
NO YES 3 3 6
NO NO 3 3 6
A At timei time of sacrifice (1, 2, 3, 6 and 12 weeks post-inoculation)
CT Recovery" Number of Mice
Vaginal Upper Tract ProgesteronePretreatment
No
Fretreatment Total
YES YES 6 0 6
YES .NO 0 0 0
NO YES 3 3 6
NO NO 0 3 3
B 2, 4, 6 weeks post-inoculation
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observation and sampling of such mice for 2*6 weeks p.i.
CT was never isolated from a mock-inoculated mouse. No other bacterial 
pathogens were detected from the routine bacterial cultures of the peritoneal swabs 
collected at the time of sacrifice from CT- or mock-inoculated mice which suggested that 
no other bacterial infection had occurred, and served as a control for the inoculation 
procedure.
Experiment!
Since penicillin treatment of CT-infected McCoy cells resulted in establishment 
of persistent CT infection in vitro, the effect of penicillin upon CT infection in vivo was 
examined. DP-pretreated C3H mice were inoculated with CT as previously described. 
At days 9 and 16 p.i., 2000 U of penicillin G were injected i.m into 34 of the CT- 
inoculated mice; 32 CT-inoculated mice remained unmedicated. The dosage of penicillin 
G used was the equivalent of a 2,000,000 U injection of penicillin G in a human. One 
of the unmedicated CT-inoculated mice died during the experiment and was excluded 
from subsequent calculations. As in experiment 1, sequential vaginal swabs were 
collected and cultured for CT. Injection of penicillin did not halt vaginal shedding of CT 
since 61.3% of CT-inoculated mice were culture-positive for CT on day 10 p.i., and 
35.3% were positive for CT on day 17 p.i. Of the unmedicated CT-inoculated mice, 
50% were positive for CT on day 10 p.i., while none were positive for CT on day 17 
p.i. Injection of penicillin did alter the pattern of vaginal CT shedding as only 64.7% 
of the penicillin-treated mice had recurrent vaginal shedding as compared to 90.3% of
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the unmedicated, CT-inoculated mice fTable 7).
At 2 weeks p.i., only 16.795 (Experiment 1) and 19.4% (Experiment 2) of the 
unmedicated CT-inoculated mice were positive for CT as compared to 62,5% of the 
penicillin-treated CT-inoculated mice (Table 8). At 2 weeks p.i., some critical event 
seemed to have occurred that resulted in the apparent "elimination" of CT from the 
vaginal vault of unmedicated CT-inoculated mice. This elimination of CT from the 
vaginal vault was also observed in nontreated, CT-inoculated mice as 0/6 were CT 
culture-negative at 2 weeks p.i. Penicillin treatment somehow modified this response, 
since vaginal CT shedding was not suppressed at 2 weeks p.i. in penicillin-treated CT- 
inoculated mice.
At 10 weeks p.i., mice that had been CT-negative for J>2 successive cultures 
were manipulated in an attempt to reactivate vaginal CT shedding (first reactivation 
group). This subpopulation of mice was injected with CA or DP, while other mice from 
this subgroup injected with saline served as controls. Of the penicillin-treated, CT- 
inoculated mice injected with CA, 1/7 (14%) exhibited transient reactivation of vaginal 
CT shedding (Table 9). Of the unmedicated, CT-inoculated mice that underwent the 
induction regimen, 28% injected with CA and 33% injected with DP had a transient 
reactivation of vaginal CT shedding (Table 9). Reactivation was not observed in any of 
the mice injected with saline (Table 9). The reactivation events were transient and only 
very low numbers of inclusions were observed (<20/coverslip). At 16 weeks p.i. (5 
weeks after induction), the first reactivation group was sacrificed and the upper tract 
tissues were cultured for CT. Infectious CT was not isolated from any animal.
Table 7 Recurrent Vaginal Shedding of CT Indicates Persistent CT Infection
in C3H Mice
Recurrent Vaginal Shedding Gross Pathology
Therapy No. Recurrent* ----------------------------- No. Positive -------------------------
No. Inoculated No. Inoculated
Penicillin0 22/34 (64.7) 24/34 • (70.6)
None 28/31 (90.3)
•
22/31 • (71.0)
* Recurrent vaginal shedding was defined as positive CT culture 
obtained after 2 or more successive negative cultures; although all 
mice inoculated eventually became negative. 
n 2,000 U i.m., days 9 and 16
Table 8 Comparison of la  Vivo Experiments
Experiment
Number Pretrealment Therapy
No. Positive/No. Inoculated
Total No. 
Positive' Weeks Post-Inoculation
No.
Inoculated I 2 4 6 12 22
1 None None 5/6 1/6 0/6 . 0/3 0/3 ND8 ND
Depo-Provera None 15/15 14/15 2/12 6/9 2/3 0/3 ND
2 Depo-Provera None 31/31 27/28c 6/31 20/30° 21/31 0/12 0/12
Depo-Provera Penicillin® 34/34 32/34 20/32F 18/34 19/34 1/13 0/13
A Number of mice exhibiting vaginal CT shedding .>.1 lime.
* Not done
c  Contaminant could not bee eliminated from cultures of three mice.
D Contaminant could not be eliminated from the culture of one mouse. 
E 2,000 U penicillin i.m., days 9, and 16
F Contaminant could not be removed from the cultures of two mice.
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Table 9 Reactivation of CT Demonstrates Persistent CT Infection
Reactivation o f  Vaginal CT SheddingA Gross Pathology
Therapy
Agent
N o. C T Positive
(%)
N o. Gross
N o, Induced N o. Inoculated
t
Cortisone-Acetate in (14) f in  (85.7)
Penicillin® Depo-Provera on (0) 5 /7  (71.4)
Saline on (0) 3 /7  (42.8)
Cortisone-Acetate 2/7 (28) 3/7 (42.8)
None Depo-Provera 2/6 (33) 5 /6 (83.3)
Saline 0/6 (0) 5 /6 (B3.3)
A Animals w ere induced at 10 weeks p .i. Only mice which had been negative for & 2 
successive cultures were induced,
Cortisone-Acetate (125 m g/kgt s .c ., every other day for 12 days)
D epo-Provera (2.5 mg, s .c ., 2  injections seven days apart)
Saline (0 .2  m l, s .c ., every other day for 12 days)
® 2,000 U  i.m ., days 9 and 16
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Of the remaining mice not included in the first reactivation group, those that had 
become CT-negative for J>J2 successive cultures were subjected to the induction regimen 
at 17 weeks p.i. None of the mice, from either the penicillin-treated group or the 
unmedicated group, became positive for CT. These mice were sacrificed at 22 weeks 
p.i. (5 weeks after induction). Infectious CT was not isolated from any of these animals. 
Further examination of the tissues from these mice, using molecular methods such as in 
situ hybridization or PCR, must be performed to determine if CT was eliminated from 
these animals or if it remains sequestered in a persistent or latent form. At the time of 
sacrifice, gross pathologic evidence of damage was observed in 70.6% of the penicillin- 
treated mice and in 71.0% of the unmedicated mice (Table 7). Although infectious CT 
was not isolated from the tissues of these mice, tissue damage had occurred. Penicillin 
treatment did not protect the CT-inoculated mice from this damage (Table 7). Further 
histopathologic examination of tissues from these mice needs to be performed to 
determine the extent and type of damage, and to determine if penicillin-treatment altered 
either of these parameters.
No pathogenic bacteria were isolated from either the aerobic or anaerobic cultures 
of peritoneal swabs collected at the time of sacrifice.
CHAPTER 4 
Discussion
The mechanism(s) of persistent CT infection are poorly understood. Using in 
vitro and in vivo models, persistent CT infection was examined at the molecular and 
cellular level. The unusual effect of penicillin upon CT infection in vitro has been noted 
in previous literature (Kramer and Gordon 1971, Johnson and Hobson 1977, Hobson et 
al. 1982). Abnormal, abortive inclusion formation was noted by Johnson and Hobson 
(1977) when penicillin-treated CT-infected cells were stained with giemsa and examined 
using dark field microscopy. These "abortive" inclusions resembled the morphology of 
the abnormal intracellular inclusions observed in penicillin-treated CT-infected McCoy 
cells stained with iodine observed in the current study (Figure 3B). As only large 
vacuoles were observed when these cells were stained with iodine, indicating that little 
or no glycogen deposition had occurred in the abnormal inclusions. The significance of 
this is unknown although it has been suggested that glycogen deposition in CT inclusions 
is not required for complete replication (Matsumoto 1988). The presence of CT MOMP 
and CT LPS in the abnormal inclusions suggests that penicillin inhibited neither CT EB 
entry nor reorganization to RB form. This supported earlier ultras tructural analysis that 
had revealed RB formation in penicillin-treated CT-infected cells, however in that study 
the RB forms were abnormally large (Kramer and Gordon 1971). The unusual deposition 
of CT MOMP and CT LPS (Figure 4B) suggests that the RB formation in the penicillin- 
treated CT-infected cells was different from that in untreated cultures, however
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ultras tructural analysts was not performed. The appearance of CT MOMP and CT LPS 
in the abnormal inclusions also suggests that penicillin treatment did not inhibit the 
synthesis of either of these antigens. Further biochemical analysis needs to performed 
to determine if these components have been altered.
Penicillin pietreatment of McCoy cells did not render the cells unable to support 
complete CT replication as even cells grown in penicillin for two weeks allowed full CT 
replication provided that penicillin was removed prior to inoculation (Figures 5 and 6). 
This result supports earlier work which showed that penicillin preincubation of McCoy 
cells did not result in loss of the ability of this cell line to support CT replication 
(Johnson and Hobson 1977). In the current study, intracellular levels of penicillin did 
not inhibit CT inclusion formation. This is in contrast to one earlier report that stated 
that in HeLa cells 4 pmol/ml penicillin could inhibit CT replication (Barbour et al. 
1982). In the same study, an intracellular concentration of 52 nmol/ml penicillin that 
was reported (Barbour et al. 1982). The difference between these results may be due to 
differences in penicillin uptake between McCoy cells and HeLa cells, however, uptake 
studies were not performed. All experiments in the present study,' where penicillin was 
removed and the monolayers washed prior to inoculation, no inhibition of subsequent CT 
replication was seen.
In the range of penicillin concentrations examined (10 U to 200 U/ml), there was 
no dose dependent response of intracellular inclusion formation or recovery of infectious 
CT (Figures 8 and 11). Although the range chosen included values above and below a 
published MIC value, it was apparently too concentrated to allow detection of a dose
dependent response (Lee et al. 1978). Reported MIC values for penicillin against CT 
vary widely depending upon the technique chosen (Blackman et al. 1977, Lee et al. 
1978, Hobson et al. 1982 , How et al. 1985). Several studies have demonstrated a dose 
dependent response in the penicillin concentration range of 0.01 to 10 U/ml (Blackman 
et al. 1977, Johnson and Hobson 1977). In the current study, initial inclusion formation 
was not inhibited although the morphology of the inclusions was altered. Furthermore, 
addition of penicillin to CT cultures drastically reduced yield of infectious CT. The MOI 
was a factor in these experiments. At a high MOI (e.g. 2.0) penicillin did not 
completely inhibit CT replication although recovery was reduced greater than 1,000,000- 
fold (Figure 10). Penicillin treatment inhibited RB maturation into EB, resulting in the 
production of defective EBs, or in the creation of some other noninfectious form of CT.
Although little or no infectious CT was produced in the penicillin-treated cultures, 
it is possible that noninfectious RBs or defective EBs were present. Since culture would 
not detect either of the latter, a cDNA probe specific for CT rRNA was employed. The 
limit of detection of the probe is 5 IFU, Additionally, the probe detects UV-inactivated 
and live CT with the same sensitivity (Figure 14). Using this probe, the kinetics of CT 
rRNA in untreated and penicillin-treated CT cultures were compared to levels of 
infectious CT detected by culture. This study examined the kinetics of acute CT 
infection in CH-treated McCoy cells. Recovery of infectious CT from supernatants or 
cell lysates from untreated cultures exhibited a typical growth curve with evidence of 
complete CT replication (Figure 15A). However, the growth curve obtained from cell 
lysates of penicillin-treated CT cultures was very different from that o f the control, with
96
a small peak of IFU production at 32 hours p .i.( gradually decreasing until no infectious 
CT were detected at 98 hours p.i.(Figure 1SB), This small peak of IFU production could 
represent either an abortive attempt at normal replication or residual inoculum. Since 
no IFU were detected in glass controls at 32 hours p.i., it could be argued that this small 
peak of IFU production was not due to residual inoculum, but this is yet to be 
substantiated.
The kinetics of CT rRNA levels in untreated and penicillin-treated cultures was 
examined. CT rRNA was detected in supernatants of untreated and penicillin-treated CT 
cultures, although lower concentrations were observed in the penicillin-treated CT- 
infected cultures (Figure 16A). The CT rRNA in supernatants reflected either release 
of CT EBs into the culture medium or release of RBs due to cell lysis. As culture was 
not performed on supernatants of penicillin-treated cultures, it was not possible to 
determine if the cell-free CT was infectious. Although this result demonstrated that some 
form of CT was released into supernatants of penicillin-treated CT cultures, the existence 
of defective EBs was neither proved nor disproved.
Cell-associated CT rRNA was detected in untreated and penicillin-treated CT 
cultures, however with two different profiles. Cell-associated recovery from control 
cultures showed the expected decrease in early hours of infection when infectious EBs 
mature into noninfectious RBs (Figure 1SB), The maturation into RBs was supported by 
the dramatic increase in the amount of CT rRNA detected between 2 and 23 hours p.i. 
when binary fission of RBs results in rapid expansion of the rRNA pool (Figure 16B). 
It has also been reported that RBs have up to three times more rRNA than EBs (Newhall
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1988). The rapid expansion of the CT rRNA pool was followed by a three log increase 
in the amount of infectious CT which demonstrated that complete replication was 
occurring in untreated CT cultures. In penicillin-treated CT cultures, a  similar trend was 
observed when cell-associated CT rRNA and CT recovery were compared. There was 
a marked decrease in the number of infectious CT early in the infection as EBs matured 
into RBs, while the concentration of CT rRNA increased dramatically until it peaked at 
25 hours p.i. (Figure 17B). This dramatic increase in the levels of CT rRNA probably 
reflects binary fission of RBs as well as a greater concentration of rRNA per RB 
(Newhall 1988). The small peak of CT recovery at 32 hours p.i. temporally followed 
the peak of CT rRNA, as was observed in control cultures that suggests that this small 
peak of production was an abortive attempt at replication. Unlike control cultures, the 
peak of CT rRNA rapidly decreased over time although the levels remained well above 
all background controls (Figure 17B). This rapid decrease in the CT rRNA pool could 
reflect either downreguladon of RB fission, downregulation of CT metabolism or 
destruction of CT. As the levels of CT rRNA remained well above background, it 
suggests that CT is harbored in these cells in some form, although RB fission may be 
slowed. It was not possible with this experimental design to determine if the levels of 
CT rRNA would continue to decrease with time, or would remain at a plateau, indicative 
of a persistent infection.
The kinetics of CT rRNA levels suggest that at approximately 25 hours p.i. 
some signal downregulated CT replication in penicillin-treated cultures. At the same 
time p.i, (25 hours p.i.) a three-log increase in cell-associated infectious CT was
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observed in untreated cultures suggesting that EB maturation was occurring (Figure 17A). 
It has been reported that penicillin inhibits the synthesis of the 60 KDa cysteine-rich outer 
membrane protein which is an important wall component in CT EBs (Moulder 1991). 
This protein is extensively cross-linked and added to the EB cell wall with two other 
cysteine-rich proteins (12 and 59 KDa) during EB maturation (Moulder 1991). Penicillin 
may have multiple effects upon CT replication: a.) inhibition of the synthesis of a protein 
necessary for EB maturation, b.) inhibition of the extensive protein-to-protein cross- 
linking found in infectious EB cell walls and c.) inhibition of EB maturation resulting in 
feedback inhibition or downregulation of RB binary fission. Since CT contains three 
penicillin binding proteins found in CT, it would not be too improbable to postulate that 
more than one enzymatic reaction could be affected (Barbour et al. 1982), Spheroplast 
formation has not been discounted by these results nor has the definitive mechanism(s) 
of penicillin action upon CT replication been elucidated. However, if the hypothesis is 
correct, then penicillin treatment of CT-infected cells in vitro should result in a type of 
persistent infection.
Since the use of CH in this first set of experiments precluded examination of long­
term persistence, another approach was employed. CT persistently-infected McCoy cells 
were cultivated either in the presence or absence of penicillin (100 U/ml). Unlike 
previous work (Lee and Moulder 1981, Benes 1990), no CH was added to the medium 
of the persistently-infected cell lines. Penicillin treatment of the initial passage resulted 
in abnormal inclusion formation consisting of vacuoles and incomplete inclusions which 
contained CT MOMP. With the exception of an occasional very small iodine-staining
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inclusion, intracellular inclusion formation was not observed in the CT-persistently- 
infected McCoy cells while maintained in penicillin medium. As was expected, recovery 
of infectious CT from the PEN cell line rapidly decreased and was undetectable after 
passage 2. CT rRNA was detectable in passages 0-2 and at very low levels in passages 
20-22 but was undetectable throughout all other passages (Figure 20). This does not 
imply that CT rRNA was not present. Rather this result may reflect that the 
representative sample size was too small (only 3.33% of the total lysate was assayed). 
Further work needs to be done to determine if CT rRNA and/or mRNA are present in 
the PEN cell line during passages 3-19. Although the PEN cell line was negative by the 
other parameters examined, passages 0-15 consistently harbored the CT genome, or at 
least a portion thereof, as the diagnostic 144 bp band was detected in amplification 
reactions using DNA extracted from the PEN cell line (Figures 26,27, and 28). As had 
been hypothesized, penicillin treatment of CT-infected cells appeared to result in 
development of persistent infection, rather than elimination of CT.
Since false positive results are a chronic problem with PCR (Kwok 1990), more 
detailed examination of the CT-persistently-infected cell lines was required. Removal 
of penicillin immediately after the initial passage resulted in a productive CT infection 
with resumption of normal intracellular inclusion formation and recovery of infectious 
CT (Figure 21). As CT replication was never completely inhibited, it is not surprising 
that this cell line rapidly recovered with only one passage (PI) in which intracellular 
inclusion formation was not noted. This was in contrast to CT-McCoy cells cultivated 
in penicillin for 3, 6, 10 or 18 passages prior to cultivation in penicillin-free medium.
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PEN3 and PENfi became negative by the parameters examined yet "recovered" to 
establish a productive CT infection that had normal intracellular inclusion formation, high 
levels of CT rRNA detected and production of infectious CT (Figures 22 and 23). PEN] 
did not exhibit inclusion formation for 3 passages in control medium yet after subsequent 
cultivation reestablished a productive CT infection. Hie "recovery" of PEN3 and PENa 
substantiates the PCR results which demonstrated that the CT genome was harbored in 
the PEN cell line during these passages.
CT-McCoy cells grown in penicillin for 10 or 18 passages prior to cultivation in 
control medium reacted quite differently than PEN,, PEN3l or PEN6, PEN10 developed 
low levels of very small iodine-staining inclusions from passages 12-20 (Figure 24). 
These inclusions did contain MOMP which indicates expression of the latter. These 
inclusions were small and pleomoiphic. Ultrastructural analysis would be required to 
determine differences between the inclusions found in the PEN)0 cell line and normal 
inclusions in untreated cells. Very low levels of CT rRNA were detectable in PEN|0 
cells, however these levels are far lower than those observed in active CT infection. No 
infectious CT was recovered from PEN10 from passages 10-20. PEN10 appeared to be 
a true persistent infection with low level antigen expression and low level replication of 
noninfectious CT, without production of infectious progeny. PEN]8 exhibited a similar 
pattern as PEN)0, yet no iodine-staining inclusions were observed even though an 
occasional small inclusion was observed when the monolayers were stained with anti- 
MOMP (Figure 25). It is unknown if further cultivation of PEN1() and PEN,j in 
penicillin-free medium would have resulted in spontaneous reactivation to a productive
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infection. Although these results support the PCR findings that the CT genome is 
harbored in the PEN line, it is unknown if the CT DNA harbored in these cells was 
damaged so that reactivation was impossible or if some required signal for reactivation 
was absent from the in vitro environment. In this regard, it has been reported that high 
levels of endogenous cyclic AMP can reactivate CT-persistently-infected BHK cells 
(MacDonald et al. 1986). Further studies of CT-McCoy cells are needed to determine 
if the CT DNA harbored in the cells treated long-term with penicillin becomes 
irreparably damaged, and to dissect the various signals necessary for reactivation to 
productive infection.
It is also unknown in what form CT is harbored in persistently-infected cells. The 
form appears to be noninfectious as it can not be detected by culture. It would seem 
reasonable that RBs are harbored, yet spheroplast formation has not yet been ruled out. 
Since infectious CT is not produced in penicillin-treated CT cultures, then some other 
mechanism of cell to cell transfer must be used. Transfer of chlamydial inclusions to 
daughter cells at cell division has been reported (Ward 1988). Transfer of the harbored 
CT to daughter cell(s) appears to have occurred since CT DNA was detected by PCR in 
CT-McCoy cells that had been cultivated in the presence of penicillin for 19 passages, 
even though no infectious CT had been detected for months in this cell line. Thus the 
CT genome appears eventually to be diluted out. This suggests that the level of 
replication in the PEN line was very low and that progeny may not be passed to both 
daughter cells upon division. However, it has not yet been determined if the harbored 
form of CT was undergoing low level replication in the presence of penicillin or if it was
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in some dormant state, i.e. a true latent infection. Molecular techniques employing 
antisense probes and in situ hybridization would be required to answer this question.
Although considered a rare epidemiologic event, there have been reports of CT 
isolates resistant to multiple antibiotics including doxycycline, erythromycin, 
sulfamethazole, clindamycin and tetracycline (Jones et al. 1990, Mourad et al. 1980). 
Examination of the PEN| cell line and its sensitivity to penicillin was necessary to 
determine if "recovery" to productive infection was due to selection of penicillin-resistant 
strains of CT. As PEN| appeared to be fully susceptible to penicillin, reactivation of the 
persistent infections did not appear to be reliant upon selection of penicillin-resistant 
strains of CT. However, since no cloning studies (including susceptibility assays of 
clones derived) were performed, it is not possible to state that no penicillin-resistant 
strains ever developed during this study.
Several other lineages of CT-McCoy cells were developed without the use of 
penicillin. McCoy cells inoculated with a high MOI of CT underwent the "wipeout” 
described by Lee and Moulder (1981), with cycles o f cell lysis followed by regeneration 
of the cell monolayer. There were several basic differences between the current study 
and earlier work reported. In earlier work, after the initial "wipeout", 100-150 days 
elapsed before productive infection was noted (Lee and Moulder 1981). The CT-McCoy 
cells generated without penicillin in our study remained overtly infected but did undergo 
episodes of cellular destruction and regeneration. In earlier work, addition of penicillin 
(16 U/ml) to CT-persistently-infected McCoy cells for 5 days-with subsequent 
cultivation in penicillin-firee medium-did not inhibit inclusion formation although it did
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delay the destructive process (Lee and Moulder 1981). In the current study, addition of 
penicillin (100 U/ml) to CT-McCoy cells developed in penicillin-free medium resulted 
in total abrogation of inclusion formation with only a low level of infection noted in the 
treated cells when they were subsequently cultivated in control medium. Although both 
studies used "McCoy” cells, there are many differences between McCoy cells from 
different sources. The discrepancies observed between the current study and earlier work 
could reflect differences between the cell lines employed, the use of CH, or differences 
between the strains of CT employed. In fact, by using a very low MOI, our McCoy 
cells could be persistently infected with CT without the cycles of destruction reported 
elsewhere (Lee and Moulder 1981, Benes 1990).
In another study, using CT-inoculated BGM cells, it was shown that addition of 
antibiotics 2  days p.i. resulted in neither abrogation of inclusion formation nor inhibition 
of infectious CT production, although both were decreased (Clad et al. 1990). The 
antibiotics tested were doxycycline, erythromycin, ciprofloxacin, and ampicillin (Clad 
et al. 1990). Once again this was in contrast to the current study in which addition of 
penicillin to persistently-infected McCoy cells completely halted inclusion formation and 
production of infectious CT for several passages, with productive infection developing 
after subsequent cultivation in control medium. Further studies are needed to determine 
why these discrepancies have occurred, and what the actual mechanism(s) are that control 
CT persistence and antibiotic susceptibility.
As has been noted previously, reported MIC values for CT vary widely depending 
upon the parameter assayed (Blackman et al. 1977, Lee et al. 1978, Hobson et al. 1982,
How et al, 1985). In vitro antimicrobial susceptibility testing is considered an acceptable 
method for determination of a  microorganism's sensitivity to different antibiotics. In the 
case of CT, however, this method may not necessarily be valid. Although penicillin is 
not the treatment of choice for CT infections in vivo, other 0-lactams are considered 
efficacious due to in vitro susceptibility testing and some human drug studies (Martin et 
al. 1986). Although the cases may not be exactly analogous, the finding that several of 
the CT-McCoy cells of the penicillin lineage remained negative by all parameters tested 
for several passages prior to becoming overtly infected suggests that in vitro 
susceptibility testing of CT may need to be examined more thoroughly. Examination of 
several parameters may be necessary to determine the true efficacy of different antibiotics 
ill vitro, including more than just a single passage in tissue culture. It may also be 
necessary to utilize molecular techniques to differentiate between development of 
persistent infection and true eradication of CT.
The effect of penicillin upon CT replication has been used as a tool to examine 
one type of persistent infection at the molecular and cellular level. Penicillin may not 
induce persistent infections in vivo or the immune response may remove persistently- 
infected cells. However, the type of abnormal inclusion observed with penicillin 
treatment has also been observed when CT-infected cells are exposed to interferon-7  
(Beatty et al. 1991). It may be that a number of cellular or molecular different signals 
can result in development of persistent infection, possibly by downregulation of EB 
production and RB binary fission until a reactivation signal is provided. The fact that 
nutrient deprivation can also result in "delayed" CT infections may help to support this
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speculation, but additional work is needed to resolve this issue.
The significance of persistent in vitro CT infections has been debated. Although 
valuable model systems for controlled study of cellular and molecular mechanisms, in 
vitro model systems can not encompass the complex immune response that occurs in 
vivo. For persistent infections to occur in vivo, a successful host cell-parasite 
relationship must be established and the infected cells must evade destruction by the 
immune responses as well. To examine persistent CT infections in vivo, a  murine model 
of upper tract CT genital infection was used. Earlier work reported that progesterone 
pretreatment of female C3H mice enhanced subsequent CT infection (Tuffrey et al. 
1986a). The murine model of CT salpingitis has become widely used to study adverse 
sequelae of severe upper tract CT infection (Tuffrey et al. 1990, Swenson et al. 1986, 
Patton 1990, Zana et al. 1991). In experiment 1, mice which had not been pretreated 
with progesterone transiently shed CT vaginally, although 50% of the mice harbored CT 
in the upper reproductive tract tissues (Table 2). All of the nontreated mice were 
sacrificed relatively early p.i. (15 and 43 days). It was notable that one mouse had not 
shed CT vaginally for over a month yet still harbored CT in the upper tract. Thus in 
nontreated CT-inoculated mice, lack of vaginal CT shedding did not reflect true 
eradication of the infection from the upper tract (Table 2).
DP-pretreatment enhanced vaginal CT colonization as CT was recovered with 
greater frequency from successive vaginal swabs (Table 4). This result agrees with our 
earlier work in which DP-pretreatment enhanced vaginal shedding of CT and 
dissemination of CT throughout the upper reproductive tract (Tau-Cody et al. 1989). An
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unexpected result was that a number of the DP-pretreated CT-inoculated mice underwent 
recurrent vaginal shedding of CT, which indicated that even successive negative vaginal 
cultures did not correlate with clearance of CT from the upper tract (Table 4). It has 
been accepted by some that successive negative vaginal CT cultures correlates with 
resolution of the infection (Igietsume et al. 1991). This result brings that assumption into 
question. Early in the infection (15 days p.i.), 8396 of the DP-pretreated mice were not 
shedding CT vaginally, yet all CT-inoculated mice sacrificed at that timepoint harbored 
CT in multiple tissues of the upper tract. This further supports the finding that CT can 
be sequestered in the upper tract, undetectable by standard assay techniques which rely 
upon cervical or vaginal specimens. In our study, CT was not isolated from the vaginal 
secretions or from upper tract tissues of any of the mice sacrificed late in the infection 
(84 days p.i.). Several other studies have indicated that mice sacrificed late in the 
infection (19 to 21 weeks p.i.) appear to have effected a bacteriologic cure since CT was 
not isolated from the upper tract tissues (Zana et al. 1990, Zana et al. 1991). It has not 
yet been determined if these mice had indeed eradicated the infection or if these mice 
harbored CT in a persistent infection undetectable by culture. Investigations employing 
molecular techniques are required to answer this question.
In the current study, gross pathologic evidence of infection was observed in 
untreated and DP-pretreated mice. Post-surgical adhesions were seen frequently in mock- 
inoculated and CT-inoculated mice, underlining a drawback of this inoculation technique. 
This murine model employs a surgical inoculation into the tip of the right uterine hom 
which is not the natural mode of infection, generating a descending infection rather than
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the natural ascending infection. This liability must be considered when scoring gross 
pathology, as some damage may be due to the trauma of surgery, not to CT infection. 
Hydrosalpinx formation, erythema and enlarged fallopian tubes were observed only in 
CT-inoculated mice and were scored as CT-specific gross pathology. In mice that were 
not pretreated with DP, isolation of CT from the upper tract tissues did not correlate with 
detectable presence or absence of gross pathologic damage (Table 2). Some mice which 
had evidence of gross pathologic damage did not appear to harbor infectious CT (Tables 
2 and 4). The mechanisms by which CT pathogenesis is produced are poorly understood 
at this time. Several mechanisms have been suggested and the damage caused by CT 
infections may be produced by more than one mechanism. As some untreated mice 
exhibited evidence of gross pathologic damage without apparent infectious CT present, 
more than one mechanism may be involved . One possibility is that the damage may 
have occurred prior to elimination of the infection. This hypothesis can neither be 
proved nor disproved by the results of this experiment as: a.) it has not been definitively 
determined whether or not CT has been eliminated from these mice and b.) the specific 
time at which the damage occurred has not been determined. In general, gross 
pathologic damage was observed in nontreated CT-inoculated mice by 6  weeks p.i., but 
was observed in DP-pretreated CT-inoculated mice, as early as 1 week p.i, (Tables 2 and 
4). "Irreversible" damage may be caused by or associated with CT replication. When 
CT is eliminated, the damage would persist. Several other mechanisms of pathogenesis 
have been suggested. Hypersensitivity has been implicated as one mechanism of CT 
pathogenesis. The most direct evidence has been the purification of a 57 KDa CT
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protein which elicits a delayed hypersensitivity reaction in the ocular model (Morrison 
et al. 1989). The role of immunopathogenesis is further implicated by studies using the 
MoPn strain of CT in a model of reactive arthritis. It has been demonstrated that 
reactive arthritis can be induced in C57B1/6 mice provided that the mice were sensitized 
by immunization or genital inoculation of MoPn prior to homologous articular challenge. 
The pathogenesis apparently occurred without active CT replication (Hough and Rank 
1988, Hough and Rank 1989). Another model examining salpingitis in CBA or C3H 
mice showed that repeated inoculations of CT resulted in greater severity of salpingitis, 
even though vaginal CT shedding was less prolonged or did not occur in the challenged 
mice (Tuffrey et al. 1990). Evidence from earlier reports and from the current work 
strongly suggest that tissue damage can occur in the absence of apparent CT replication 
and that the immune response to CT infection may be both protective and destructive. 
It has also been reported that tetracycline treatment during the first week of infection 
could prevent subsequent development of infertility in CT-inoculated mice but treatment 
given after 1 week p.i. had little protective effect (Swenson et al. 1986). This suggests 
that even successful antibiotic treatment that halts CT replication may not prevent 
subsequent sequelae from developing. A variation on the theme of CT 
immunopathogenesis is that the mice become CT-persistently-infected in vivo- The 
chronic inflammatory reaction thus induced eventually leads to tissue damage, either 
through the presence of inflammatory cytokines (TNF-a), through scarring or deciliation 
of the tubal mucosa or through other immunopathogenetic mechanisms, such as 
autoimmunity. Histopathologic examination of the tissues from the nontieated CT-
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inoculated mice in our study may help explain the results observed by detailing the 
presence and type of microscopic damage.
Similar results were obtained when the gross pathology of DP-pretreated CT- 
inoculated mice was examined. At the time of sacrifice 73.3% of the mice exhibited 
gross pathologic evidence of CT-specific damage (Table 4). As DP-pretreatment seemed 
to enhance dissemination and replication of CT in mice, many mice sacrificed during the 
timecourse of the experiment were still CT positive at the time of sacrifice. Of the 3 
mice sacrificed at day 84 p.i. one had a hydrosalpinx in the absence of either a positive 
vaginal or upper tract CT culture. An analogous argument can be made for the 
immunopathogenetic response to CT infection in DP-pretreated mice, however the effect 
of DP upon this response has not yet been determined. Histologic examination of the 
tissues from the DP-pretreated CT-inoculated mice must be performed to determine the 
presence and type of damage. These results must then be compared to the type of 
damage that had occurred in nontreated CT-inoculated mice to determine if DP had 
altered this parameter of infection.
Further analysis of the results from experiment 1 revealed that a valuable model 
to examine CT persistent infection in vivo would be inoculation of C3H mice without 
DP-pretreatment followed by observation and sampling at 2-6 weeks p.i. Although these 
mice only transiently shed CT vaginally, CT was harbored in the upper tract tissues of 
50% of the mice and gross pathologic evidence of infection was observed (Table 6), 
This model may prove to be the most productive for investigation of the effect of various 
antibiotics upon "persistent" CT infection in vivo, i.e. whether or not the antibiotic under
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investigation truly eradicates CT infection or results in the establishment of a persistent 
infection.
Since penicillin treatment of CT-infected McCoy cells resulted in establishment 
of persistent CT infection in vitro, the effect of penicillin upon CT infection in vivo was 
examined in experiment 2. The penicillin regimen employed was i.m. injection of 2000 
U of penicillin G at days 9 and 16 p.i., a dosage that was equivalent to 2,000,000 U in 
an average size human. Unexpectedly, penicillin treatment of DP-pretreated CT- 
inoculated mice did not halt vaginal shedding of CT (Table 7). This unexpected result 
may be due to several factors. It has been reported that the serum half life of 
amoxycillin and clavulanic acid (both /S-lactams) in mice was 1/2 to 1/10 as long as the 
serum half lives of the same two antibiotics in humans (Beale et al. 1991). It is possible 
that the treatment regimen employed did not allow sufficiently high concentrations of 
penicillin to be achieved for a  duration long enough to affect CT replication. Another 
factor may be the genital bioavailability of the penicillin G solution injected. The latter 
was not examined. Injection of penicillin did alter the pattern of vaginal CT shedding 
as only 64,7% of the penicillin-treated mice exhibited recurrent vaginal shedding 
compared to 90.3% of the unmedicated CT-inoculated mice (Table 7). More detailed 
analysis of the results revealed that at 2 weeks p.i., only 16.7% (experiment 1) and 
19.4% (experiment 2) of the unmedicated CT-inoculated mice were vaginally shedding 
CT as compared to 62.5% of the penicillin-treated CT-inoculated mice at the same 
timepoint (Table 8). None of the nontreated, unmedicated, CT-inoculated mice were 
shedding CT vaginally at 2 weeks p.i. At 2 weeks p.i. some critical event appears to
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have occurred which resulted in the apparent "elimination" of CT from the vaginal vault 
of unmedicated CT-inoculated mice. At this time it is unknown what caused this 
"elimination" and why it would be modified by the penicillin treatment employed. It is 
possible that penicillin in vivo induces a persistent or sequestered CT infection in some 
form which escapes the immune response, but this is speculation.
At 10 weeks p.i., mice which had been CT-negative for >2  successive cultures 
were induced with CA or DP in an attempt to reactivate vaginal CT shedding. Mice 
from the same subpopulation were injected with saline to serve as controls. CA had been 
demonstrated to reactivate CT lung infections in mice (Yang et al. 1983). As DP- 
pretreatment has been demonstrated to enhance the susceptibility of mice to CT genital 
infection, it was tested to ascertain if it also could reactivate vaginal CT shedding. 
Penicillin treatment did reduce the number of mice that underwent reactivation of vaginal 
CT shedding as only 1/7 mice injected with CA had a transient reactivation of vaginal 
CT shedding, while none of the mice injected with either DP or saline became CT- 
posidve (Table 9). Of the unmedicated CT-inoculated mice that underwent induction, 
28% injected with CA and 33% injected with DP had a  transient reactivation of vaginal 
CT shedding, while none of the mice injected with saline became positive for CT (Table 
9). These reactivation events were transient and only low numbers of inclusions were 
observed. These results suggest that penicillin treatment reduced the number of mice in 
which a persistent CT infection was established which could be reactivated by CA or DP, 
but further work is needed to determine this. In the model of CT lung infection 
reported, only 33% of the mice that underwent steroid induction experienced reactivation
of the CT infection (Yang et al. 1983). It is possible that only a portion of the mice 
inoculated with CT actually develop a  chronic persistent CT infection or it may be that 
these induction protocols did not provide the most efficient reactivation signals. It could 
be important to determine what events caused the persistent infection only in some mice, 
since the inbred mice employed in this study are 99.99% genetically identical. 
Understanding differential response to CT infection among individuals with the same 
genetic background may allow better comprehension of CT pathogenesis overall. No 
infectious CT was recovered from the upper tract tissues of any animal in the first 
reactivation group at the time of sacrifice (16 weeks p.i.). As noted before, it is 
unknown at this time if CT had been truly eliminated from these mice or was simply in 
a form of persistent infection which was undetectable by culture. A second 
subpopulation of mice from this experiment underwent the same induction regimen as 
described except induction began at 17 weeks p.i. None of the mice from any group 
became CT-positive and infectious CT was not recovered from any animal at the time 
of sacrifice (22 weeks p.i.). Further analysis of the tissues from these mice using 
molecular methods such as in silu hybridization or PCR must be performed to determine 
if CT had been eradicated from these animals or remained sequestered in a persistent or 
latent form.
Gross pathologic evidence of tissue damage was observed at the time of sacrifice 
in 70.6% of the penicillin-treated mice and 71.0% of the unmedicated mice, even though 
infectious CT was not recovered from any of these animals (Table 7). This supports 
earlier findings that active CT replication may not be necessary for pathogenesis.
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Penicillin treatment did not protect the CT-inoculated mice from this damage. This lack 
of protection by penicillin may be the result of an inefficacious therapeutic regimen, or 
it may be due to the late start of antibiotic therapy (9 days p.i.), as was seen in a mouse 
model mentioned earlier, in which tetracycline treatment started after 1 week p.i. did not 
protect against subsequent infertility (Swenson et al. 1986). Histologic examination of 
the tissues from these mice must be performed to answer some the unresolved questions 
from this experiment.
As with in vitro testing of CT susceptibility to various antimicrobial agents, the 
ability of CT to establish undetectably persistent infections in vivo may require a closer 
examination of results obtained from animal models and human studies of CT antibiotic 
susceptibility. Traditionally these studies rely upon cervical or vaginal elimination of CT 
as test of cure. Antibiotic susceptibility assays in animal models allow for examination 
of upper tract tissues by molecular methods to determine if CT had been cleared by an 
antibiotic or simply forced into a persistent infection undetectable by commonly used 
assays. With human drug studies, however, the question can not be addressed as 
directly. All such studies use elimination of CT from cervical specimens as test of cure. 
This is necessary as laparoscopy, which would allow tubal biopsies to be obtained for 
further analysis, is an invasive procedure that should not be performed unless warranted. 
At this time, laparoscopic examination of all women undergoing treatment for CT to 
determine efficacy of cure is unreasonable. However, the problem does exist. In one 
study, infertile women underwent laparoscopy and tubal biopsies from some of these 
women were CT positive, even though the women had negative endocervical CT cultures
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(Henry-Suchet 1988). Serology is not diagnostic of persistent CT infection as CT- 
specific antibodies can persist for years (Mardh et al. 1989). Understanding of the 
mechanistn(s) of CT persistence may allow for better assessment of what factors may put 
a person at risk of establishing a persistent infection, which if not treated correctly, may 
be reactivated to cause eventual damage.
*
A better understanding of the protective and pathogenic aspects of the immune 
response to CT, the nature of persistent or latent CT infections in vivo and the response 
of CT to various antibiotics could be vital. With in vitro and in vivo models now 
available to examine these questions at the molecular level, it could become possible to 
better assess which women may be at risk for the more serious sequelae of CT infection 
and permanent tissue damage. Among the unresolved questions concerning CT 
pathogenesis, the role of CT persistence and/or latency may prove pivotal, as so many 
critical decisions are based upon the assumption that a negative cervicovaginal specimen 
correlates to clearance of the infection. Persistent CT infections could force a 
reevaluation of many assumptions and have a significant impact upon the clinical 
management of this infection.
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